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Combined minimal medication and psychosocial interventions in acute-phase 
schizophrenic psychosis are seen by many as the way to address the problems 
inherent in the use of antipsychotic medication as the mainstay treatment for 
schizophrenic psychosis. This research report explores the Knowledge, Attitudes, and 
Practices of South African psychiatrists working in public hospitals with regard to 
these alternative interventions. Eight psychiatrists were interviewed using a self-
designed semi-structured questionnaire consisting mostly out of open-ended 
questions. A qualitative approach was adopted, while thematic content analysis was 
used to identify themes that address the aims of the research. Analysis revealed that: 
None of the participants had any in-depth knowledge of combined minimal 
medication and psychosocial interventions in acute-phase schizophrenic psychosis, 
while one participant was aware of their existence; The participants were 
unanimously opposed to the use of psychological interventions in acute-phase 
schizophrenic psychosis, as medication is viewed as the mainstay in treatment, with 
psychosocial and psychological interventions seen only as an adjunct, and 
contraindicated in the acute phase; Schizophrenia is viewed as a biological disorder; 
The majority of participants were not willing to minimize or withhold medication, as 
psychosis is seen as toxic to the brain, while one participant did report delaying 
medication in cases where there was uncertainty around diagnosis; The lack of 
resources in South African mental health care greatly influences treatment 
approaches.     
1.) INTRODUCTION  
 
Schizophrenia is one of the most serious and debilitating mental health disorders 
treated by psychiatrists today. It places massive physical, cognitive, and emotional 
burdens on the sufferer, family members, and caregivers, and has immense financial 
implications for those involved as well as for the country (McEvoy, 2007). The 
disorder has a very poor outcome, and is characterized by a spectrum of symptoms 
that include hallucinations, delusions, disorganized speech, grossly disorganized or 
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catatonic behavior, flattened affect, and an impairment of goal-directed behavior 
(American Psychiatric Association, DSM-IV-TR, 2000). Schizophrenia is also one of 
the most stigmatized mental disorders, creating a vicious cycle of social 
discrimination and breakdown of social networks for sufferers (Rössler, Salize, Os, & 
Riecher-Rössler, 2005).  From a professional point of view the matter is further 
complicated as the accuracy and applicability of the definition of the disorder is in 
dispute (Boyle, 1990; Kennard, 2009). These difficulties and debates are accompanied 
by a more practical contention, however, which is how schizophrenia should be 
treated and whether non-medical interventions, such as psychosocial interventions, 
have a significant role to play, or not, within the practical reality of clinical care 
today.  
The treatment of schizophrenia is a highly complex affair, with the call for an 
integrated approach to its treatment having grown markedly over the last decade 
(Alanen, Chávez, Silver & Martidale, 2009). The discussion surrounding the optimal 
treatment of patients suffering from schizophrenia is in great part focused on the 
debate between those who support purely biological science and those who support 
the implementation of psychological and/or psychosocial interventions to aid 
biological treatment (Alanen et al., 2009; Aaltonen, Alanen, Cullberg, Haugsgjerd, 
Levander & Rosenbaum, 2009). Particularly in the United States of America (USA) 
those advocating the use of psychological and/or psychosocial interventions report 
feeling like they are caught up in a never-ending battle with what they refer to as 
‘biological reductionism’ (Koehler & Silver, 2009). The implementation of 
psychological and/or psychosocial interventions in schizophrenia is being opposed by 
a number of factors that include: the natural science tradition’s reluctance to develop 
an adequate respect for alternative theoretical outlooks due to its commitment to 
medical research and education; the belief that schizophrenia is exclusively a brain 
disorder that is unrelated to psychological elements, apparently supported by the 
development of brain research; the pharmaceutical industry’s strong position of 
influence; and the assumption that psychological interventions in schizophrenia are 
not applicable in the wider public health area due to a lack of resources (Olanen, 
2009). The main reason given for the lack of clear and in-depth recommendations for 
psychological interventions is a general lack of quality evidence that supports its 
efficacy (Lehman & Steinwachs, 1998a; Olanen, 2009). Exactly how realistic the 
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possibility of implementing psychological interventions are in the treatment of 
schizophrenia in South Africa, remains unclear, in part due to factors such as the 
absence of locally relevant treatment guidelines, the relative lack of comprehensive 
studies that look at the practices of psychiatrists regarding the treatment of this 
disorder in the South African context, and in part the under-resourced nature of health 
care in South Africa (Koen, Magni, Niehaus, & le Roux, 2008; Trump & Hugo, 
2006). These debates form the context for this study, and encompass some of the 
crucial elements that could influence the way a psychiatrist views and treats 
schizophrenia. It is also precisely these factors that the researcher aims to investigate 
to determine what South African psychiatrists’ knowledge, opinions, and practices are 
regarding minimal medication interventions in schizophrenia. For the rest of the 
paper, the terms ‘schizophrenia’ and ‘acute-phase schizophrenic psychosis’ will be 




The pivotal aims of the research study are: 
1. To explore the knowledge of South African psychiatrists of combined minimal 
medication and psychosocial interventions in acute-phase schizophrenic 
psychosis. 
2. To explore the attitudes of South African psychiatrists toward combined 
minimal medication and psychosocial interventions in acute-phase 
schizophrenic psychosis. 
3. To explore the practices of South African psychiatrists with regard to the 







Mental health care professionals’ frustration with the different approaches to 
treatment of acute-phase schizophrenic psychosis used by other individuals, 
institutions, and countries, continues to be a theme that sparks heated debate between 
those involved. There are several different schools of thought regarding the treatment 
of acute-phase schizophrenic psychosis, and the way that any specific school 
influences a clinician’s thinking, will invariably have an effect on his or her treatment 
approach. A great deal of psychiatrists regard schizophrenia as a mental disorder with 
an internal biological cause that can often be traced to a specific genetic abnormality, 
which should be treated primarily with antipsychotics as it responds unfavorably to 
psychotherapy (Laungani, 2002; Ross, 2006). Others view environmental factors such 
as communication difficulty and hostility within dysfunctional family context, abuse, 
racism, social marginalization, and early loss of parents or caregivers, as significant 
contributors to the development of schizophrenia (Koehler, 2004; Read, Seymour, & 
Mosher, 2004). This view adds to the ever-expanding body of research that views 
schizophrenia as a disorder of social cognition (Lewis, 2008). Lewis (2008) further 
clarifies social cognition as “the capacity to mentally represent self and other as a 
guide to social interaction”, and states that there are numerous studies that support this 
view, finding that these deficits present themselves throughout the course of 
schizophrenia, and that they may persevere in spite of the use of antipsychotics (p.54). 
Many of the proponents of psychological interventions reflect negatively on the 
exclusive use of antipsychotics by stating that the patients, as well as their families, 
are settling for treatment methods that propose to make the patient a life-long invalid 
who does not upset others too much (Karon, 2003).  
The researcher agrees with the viewpoint that effective clinical reasoning is based on 
several different types of knowledge, and that, because there are many complications 
and problems inherent in the various approaches to the treatment of acute-phase 
schizophrenic psychosis, this attitude seems crucial (Hietala, 2009; Higgs & Titchen, 
1995). In the search for approaches that address these problems, and in particular 
problems related to antipsychotic use that include fatigue and lack of energy, poor 
concentration, a decrease in libido, problems related to sexual performance, 
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disturbances in sleep patterns, having a dry mouth, and anxiety, there has been a 
development of innovative minimal medication programs combined with 
psychological interventions that provide an unmistakable polarity to the medical 
practices of developed countries (Bola, Lehtinen, Cullberg, & Ciompi, 2009; Trump 
& Hugo, 2006). Instead of institutionalizing and immediately treating acute first-
episode schizophrenia patients with antipsychotics, these pilot programs clearly show 
the practicality of the combination of specifically developed psychological treatments 
with time-limited antipsychotic medication postponement (Bola et al., 2009). It can be 
argued that psychological intervention is a vital part of the treatment of psychosis 
(Jackson, 2009). Approaches such as those based on psychodynamic theory can assist 
clinicians working with patients suffering from schizophrenia, and aid them in finding 
meaning in eccentric and bizarre communications (Jackson, 2009). Mental health 
professionals working with psychotic individuals also find themselves in a highly 
stressful environment, and could benefit from a theoretical framework that increases 
their ability to understand the patient, and to relate to his/her experience (Jackson, 
2009). A psychodynamic understanding of psychosis greatly supplements the 
understanding of empirical findings of interpersonal processes communicated in 
psychosis (Martindale, 2008). Jackson (2009) references Freud as proposing the 
following:  
…So many things that in neurosis have to be laboriously fetched up from 
the depths are found in psychosis on the surface, visible to every eye. For 
that reason the best subjects for the demonstration of many of the 
assertions of psychoanalysis are provided by the psychiatric clinic…in the 
long run even the psychiatrists cannot resist the convincing force of their 
own clinical material (p.78). 
Others hold a more cautious and skeptical view. Hoffman (2009) cites Carl Jung 
stating that: 
…The psychogenesis of schizophrenia also explains why certain lighter 
cases…can be psychotherapeutically cured. But one should not be too 
optimistic with respect to this possibility of cure. These are rare cases, for 
the nature of the illness and the decay of the personality hinder precisely 
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the active agency of the therapy, namely the exertion of psychic influence 
(p.41). 
The findings and arguments of these groundbreaking studies do, however, stand 
outside the currently permitted body of treatment recommendations as set out by the 
American Psychiatric Association (APA), the Patient Outcomes Research Team 
(PORT), and Britain’s National Health Service’s (NHS) National Institute for Health 
and Clinical Excellence (NICE) (American Psychiatric Association, 2009; Lehman & 
Steinwachs, 1998a; National Institute for Health and Clinical Excellence, 2009). The 
fact that South Africa does not have locally relevant treatment guidelines for 
schizophrenia, provincial or national, further adds to the difficulty of combining the 
relevant pharmacological and therapeutic elements to treat South African patients 
suffering from schizophrenia (Koen et al., 2008). This also makes it very difficult to 
determine the legitimacy of different clinicians’ approaches to the treatment of 
schizophrenia (in all phases), as there is not a locally relevant baseline to measure 
differences against. The lack of resources in South Africa in terms of health care, and 
the fact that many people are not receiving a high level of service, further compound 
the situation, particularly because these alternative methods of intervention could 
potentially demand even more resources (Bola et al., 2009; Trump & Hugo, 2006). 
These factors all heavily contribute to the need to determine what psychiatrists in 
South Africa consider important and effective in the treatment of acute-phase 
schizophrenic psychosis, and why.  
 
4.) LITERATURE REVIEW 
 
4.1.) Global Prevalence and Statistics of Schizophrenia 
The global prevalence of lifetime schizophrenia is estimated to be between 14 and 55 
people for every 10 000 and between 33 and 34 people for every 10 000 in terms of 
the one-year prevalence of the disorder (Goldner, Hsu, Waraich, & Somers, 2002; 
Jablensky, 2000; Saha, Chant, Welham, & McGrath, 2005). The grave implications of 
this disorder are clear, as it remains one of the major contributors to the worldwide 
encumbrance of disease (Saha et al., 2005). Life expectancy of those suffering from 
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schizophrenia is reduced by roughly 10 percent, with between 4.9 and 13 percent 
committing suicide (Rössler et al., 2005; Tatarelli, Pompili, & Girardi, 2007). To 
better quantify the burden of schizophrenia, the Global Burden of Disease (GBD) 
methodology uses a metric that calculates the disability-adjusted life year (DALY) of 
an individual suffering from this disorder, basically constituting the loss of a healthy 
year of life (Rössler et al., 2005). In terms of the global burden of disease, 
schizophrenia accounts for approximately 1.1 percent of the DALY loss, a significant 
amount that contributes to schizophrenia being listed as the 8th leading cause of 
disability-adjusted life years worldwide (Rössler et al., 2005). 
 
4.2.) Prevalence and Statistics of Schizophrenia in South Africa 
Mental illness is a devastating force in South Africa (Trump & Hugo, 2006). The 
South African Association of Psychiatrists reports that 58 percent of visits to general 
practitioners are the result of circumstances that are generated from, or made worse by 
mental illness (Trump & Hugo, 2006). Literature on the current prevalence rate of 
schizophrenia in South Africa is lacking, but it is estimated that 1 percent of the South 
African population suffers from schizophrenia, amounting to a figure of roughly 500 
000 people (following census estimates of population size) suffering from this 
disorder at any given time (Trump & Hugo, 2006). Loss of productivity as a result of 
early onset and early retirement, as well as the financial burdens on families and 
caregivers are among the factors that make schizophrenia a very expensive disease for 
the country to deal with (McEvoy, 2007; Rössler et al., 2005).  
 
4.3.) Tertiary Health-Care as it Exists Today 
Despite the substantial financial implications of schizophrenia on the health care 
system, South Africa does not have national or provincial treatment guidelines 
developed specifically in South Africa to regulate the practices of professionals in 
mental health care working with schizophrenia (Koen et al., 2008). The effect of this 
is visible in a recent study that looked at the clinical practices of three psychiatric 
hospitals in the Western Cape (Koen et al., 2008). It was found that the participating 
hospitals had differing treatment approaches, and evidence of antipsychotic 
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polypharmacy was found with a rate of 28.6 percent, a significantly higher rate than in 
other countries such as the USA and New Zealand (Koen et al., 2008).  
Treatment guidelines such as those put forward by the APA (2009), the PORT 
(1998a; 1998b; 2009) and the NICE (2002) provide clear guidelines based on a 
substantial amount of scientific research. The implementation of these guidelines in 
South Africa is, however, not a straightforward endeavor (Koen et al., 2008). These 
guidelines were established in developed countries, and the picture regarding the 
availability of mental health care in a developing country such as South Africa, 
simply does not look the same (Emsley & Booysen, 2004). Developing countries tend 
to have an absence of decentralized mental health services; mostly find new 
generation antipsychotic drugs to be too costly; and in many instances have an 
absence of essentially patient-centered mental health legislation, all of which are 
factors that need to be taken into account in the formation and implementation of 
treatment guidelines in South Africa (Burns, 2008). The cost effectiveness or cost 
neutrality of new generation atypical antipsychotics as indicated in developed 
countries is another factor that has become questionable in terms of its relevance in 
developing countries (Emsley & Booysen, 2004). Atypical antipsychotics are very 
expensive, and many of the developing countries including, South Africa, simply 
cannot afford them, thus relying on classical antipsychotics in state health services, 
leaving patients at greater risk to experience extrapyramidal side effects (Emsley, 
Oosthuizen, Joubert, Hawkridge & Stein, 1999). The direct financial demand of 
schizophrenia on a country’s health-care system includes the cost of the treatment 
provided in inpatient care, outpatient care, as well as long-term care (McEvoy, 2007). 
To give the reader an idea of the severity of the cost, the United States of America 
spent the equivalent of R438.8 billion in 2002 on schizophrenia and related factors 
with a calculated prevalence rate of 51 people for every 100,000 (McEvoy, 2007). 
Unfortunately a search of the literature has failed to present similar data in terms of 
the expenditure in South Africa. The fact is, however, that South Africa does not 
possess a health-care system that can be compared to those found in the USA, Europe, 
or the UK’s NHS. A lot of people in South Africa simply do not receive the level of 
mental health care that they require due to restrictions imposed by many of the 
medical aid service providers for mental health conditions (Trump & Hugo, 2006). 
Those medical aid service providers that do cater for mental illness, place a limit on 
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the available benefits, making it incredibly difficult for patients to recover completely 
(Trump & Hugo, 2006). This is reflected by the high percentage of mental health 
consumers who terminate psychotherapy and medication because of financial 
implications – 46 percent discontinuing therapy, of which more than half state that 
medical aid funds were depleted, and 23 percent discontinuing medication based on 
financial constraints (Trump & Hugo, 2006). One has to wonder whether the South 
African health care system, notwithstanding all of the negative factors involved, can 
accommodate minimal medication interventions in schizophrenia that incorporate 
psychological interventions, especially since these types of interventions are typically 
executed in closely monitored, multidisciplinary, 24 hour facilities (Bola et al., 2009). 
It should also be noted that, compared to pharmacological interventions, 
psychological interventions are considerably more expensive to establish, the 
recruitment of participants is a difficult task, and a great deal of resources are needed 
to ensure the quality and consistency of the therapy, all of which are factors that could 
heavily strain the South African health care system (Gleeson, Krstev, & Killacky, 
2008). 
The exploration of the limitations of health care settings in South Africa with regard 
to the implementation of psychological interventions is a much-needed endeavor, and, 
although beyond the scope of this study, will hopefully be done in part when looking 
at the attitudes of psychiatrists towards these innovations in South African context.  
 
4.4.) Treatment Guidelines 
The fidelity and quality of mental health care is largely built on evidence-based 
psychiatry and treatment guidelines (Kozumplik & Uzun, 2009). The development of 
these treatment guidelines for schizophrenia are influenced by a number of factors 
that include: the impact on budget and outcomes; patient tolerability, safety, and 
efficacy; new treatments; updated information regarding new treatments; and the 
experiences of users (Buckley, Miller, Chiles, & Sajatovic, 1999). In 1992 in the 
USA, the Agency for Health Care Policy and Research (AHCPR) in association with 
the National Institute of Mental Health, founded the Patient Outcomes Research Team 
(PORT) (Lehman & Steinwachs, 1998a). The PORT combines the expertise of three 
of the leading research centers, has as its main purpose the development of treatment 
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recommendations for individuals suffering from schizophrenia, and remains among 
the most referenced treatment guidelines for schizophrenia (Larsen, 2008; Lehman & 
Steinwachs, 1998a). The treatment recommendations that are put forward by the 
PORT report is claimed to be based on a substantial body of scientific evidence, but 
seems lacking in terms of alternative treatment recommendations that incorporate 
psychotherapy (Lehman & Steinwachs, 1998a). The authors do, however, 
acknowledge this, and state that psychological interventions are not seen as less 
effective than the use of antipsychotics, but that they are left out because of the lack 
of scientific evidence supporting their efficacy (Lehman & Steinwachs, 1998a). Each 
treatment recommendation is substantiated with a rationale that links it to a supporting 
body of scientific evidence (Lehman & Steinwachs, 1998a). Only the first five 
recommendations, as well as recommendation number twenty-two will be looked at in 
this paper, as they are central to the themes covered and constitute some of the factors 
that could influence the treatment of schizophrenia. Lehman and Steinwachs (1998a) 
state the first treatment recommendation as follows: “Antipsychotic medication, other 
than clozapine, should be used as the first-line treatment to reduce psychotic 
symptoms for persons experiencing an acute symptom episode of schizophrenia” 
(p.2). Lehman and Steinwachs (1998a) rationalize this recommendation by stating 
that: 
…Over 100 randomized double-blind studies consistently support the 
efficacy of antipsychotic medications relative to placebo in reduction of the 
acute positive symptoms (hallucinations, delusions, thought disorganization, 
bizarre behavior) of schizophrenia. Approximately 50 to 80 percent of 
persons will improve significantly with this treatment compared with about 
5 to 45 percent on placebo (p.2). 
The second recommendation states that the minimum dosage should be used (300-
1000 chlorpromazine equivalents per day), with the third recommendation following 
that the level of dosage should always remain in the lower end of the spectrum 
(Lehman & Steinwachs, 1998a). Recommendation four advises against massive 
loading doses of antipsychotics, or ‘rapid neurolpeptization’ (Lehman & Steinwachs, 
1998a). The fifth recommendation deals with factors that influence the choice of 
antipsychotic, and states that it should be based on the patient’s acceptability, prior 
individual drug response, long-term treatment plan, and side-effect profile (Lehman & 
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Steinwachs, 1998a). With regard to the use of psychotherapy, recommendation 
twenty-two states that individual as well as group psychotherapy (based on a 
psychodynamic paradigm), even in combination with the use of antipsychotics, should 
not be implemented in the treatment of schizophrenia (Lehman & Steinwachs, 1998a). 
The supporting rationale states that, as mentioned previously, there is not a sufficient 
body of scientific evidence supporting its use (Lehman & Steinwachs, 1998a). Silver 
(2000) attacks the validity of the previous recommendation made against the use of 
psychodynamic psychotherapy, and states that it is based on the work done by Scott 
and Dixon (1995) in which they looked at psychological interventions for 
schizophrenia, and, instead of doing a meta-analysis, doing a literature review that 
lacked in depth and scope. One could also argue that, even though alternative forms of 
psychotherapy were not advised against, their complete absence in the 
recommendation makes them seem less than important.     
In terms of the implementation of the recommendations made by the PORT, Lehman 
and Steinwachs (1998b) discuss the results of a survey done by the PORT that looked 
at the correspondence of current treatment plans with the recommendations made. The 
PORT surveyed a random stratified sample of 716 patients that were diagnosed with 
schizophrenia, and found that the correspondence rates between recommendations and 
actual treatment provided was less than 50 percent (Lehman & Steinwachs, 1998b). In 
light of this, the PORT made the following recommendation (number twenty-three) 
with regard to the use of psychological treatments: 
…Individual and group therapies employing well-specified combinations 
of support, education, and behavioral and cognitive skills training 
approaches designed to address the specific deficits of persons with 
schizophrenia should be offered over time to improve functioning and 
enhance other target problems, such as medication noncompliance 
(Lehman & Steinwachs, 1998b, p.17). 
It is important to note that, although no psychodynamic-based treatment is mentioned, 
it is not advised against as in previous reports (Lehman & Steinwachs, 1998a).  
As research evolves, the PORT has revised their recommendations, with the first 
update done in 2003 (Dixon, Dickerson, Bellack, Bennett, Dickinson, & Goldberg et 
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al., 2009). The recommendations that were published in December 2009, as relevant 
to this paper, state that the following therapeutic interventions are advisable for 
persons suffering from schizophrenia; Assertive Community Training (ACT), 
Supported Employment, Skills Training, Cognitive Behavioral Therapy (CBT) – in 
addition to an established pharmacotherapy regimen to aid the alleviation of persistent 
psychotic symptoms, and Token Economy Interventions (Dixon et al., 2009).  
Psychosocial interventions are indicated for factors that are occasionally associated 
with schizophrenia, such as substance abuse – for which ACT, Motivational 
Enhancement (ME), and CBT are prescribed, and weight management problems – for 
which, among others, behavioral self-management and ME are recommended (Dixon 
et al., 2009). Once again, no psychodynamic-based approaches are mentioned. 
The most recent set of treatment guidelines for schizophrenia as provided by the APA 
state that “treatment with antipsychotic medication is indicated for nearly all episodes 
of acute psychosis in patients with schizophrenia” (American Psychiatric Association, 
2009). The guideline further states that treatment with antipsychotics should be 
commenced as soon as is clinically practicable (APA, 2009). The delay of treatment is 
advised to be justifiable only in cases where patients need further diagnostic 
evaluation, patients refuse to take medications, or patients experience a rapid recovery 
as a result of severe stress or substance abuse accounting for their psychotic 
symptoms (APA, 2009). Needless to say, these recommendations leave very little 
room for alternative interventions supplemented by lower dose antipsychotics in the 
acute phase. The use of psychosocial interventions are recommended only in the 
stable phase, with approaches such as family interventions, supported employment, 
social skills training, ACT, and cognitive behaviorally orientated psychotherapy being 
associated with improved outcomes (APA, 2009). A supplement to these guidelines 
can be found in the latest version of Guideline Watch (Dixon, Perkins, & Calmes, 
2009).  
Treatment guidelines as stated by the NICE functioning under Britain’s NHS provide 
a significantly clearer picture regarding the implementation of psychological 
interventions in the treatment of schizophrenia (NICE, 2002). Since 2002 family 
intervention therapy as well as CBT have been approved as treatments that should be 
made available to all NHS patients (Kennard, 2009; NICE, 2002). This guideline cites 
psychological treatments as a crucial component in the treatment of schizophrenia, 
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stating that these forms of intervention should be used to ameliorate symptoms, 
decrease the risk of relapse, improve insight, and support compliance with medication 
(NICE, 2002). As stated, neither this recommendation, nor the ones made by the 
PORT and the APA respectively advocate the use of a psychodynamic-based 
approach. This is very likely due to the fact that, although both CBT and 
psychodynamic theory claim to be evidence-based, psychodynamic theory’s evidence 
is based on clinical observation in therapeutic settings, whereas the evidence 
supporting CBT is based on systematic research that implements quantified 
observations of clinical samples (Kennard, 2009). Karl Popper (In Bentall, 2006) goes 
as far as stating that, because psychodynamic theory is unfalsifiable, it is unscientific 
and therefore carries no weight. The lack of scientific evidence supporting the 
efficacy of psychodynamic interventions is, however, defended by some who argue 
that, due to the delicate and personal nature of psychotherapy and the fact that it is 
more reliant on relationships than technique, randomized trials are probably not the 
most effective method to scrutinize it (Hinshelwood, 2002).     
South Africa currently does not have comprehensive treatment guidelines for 
schizophrenia that are based on South African-specific needs and research done in 
South Africa (Koen et al., 2008). The Standard Treatment Guidelines and Essential 
Drug List for South Africa, as stipulated by the Department of Health, covers the 
majority of health care in the country (Department of Health, 2008). The three page 
section devoted to schizophrenia affirms that it is the most common psychotic 
disorder and states that family counseling, psycho-education, CBT in stabilized 
patients, and group therapy could be used as supportive interventions (Department of 
Health, 2008). This is the only reference with regard to psychological interventions. 
The guideline further recommends the use of antipsychotic medication as treatment 
for schizophrenia listing haloperidol, chlorpromazine, lorazepam, zuclophentixol 
acetate, and benzodiazepines respectively based on the level of sedation needed, 
acuteness of psychosis, and aggression of the patient (Department of Health, 2008).  
The implementation of psychological interventions in South Africa will clearly have 
to be preceded by the development and implementation of comprehensive South 
African-specific treatment guidelines that will regulate and support these 
interventions. 
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4.5.) Problems Related to Current Treatment Approaches in Acute-Phase 
Schizophrenic Psychosis 
The most severely experienced side effects of antipsychotic medication as reported by 
South African mental health consumers are; fatigue and lack of energy, poor 
concentration, a decrease in libido, problems related to sexual performance, 
disturbances in sleep patterns, having a dry mouth, and anxiety, with between 33 and 
50 percent of patients suffering from schizophrenia reporting at least one of these 
symptoms (Trump & Hugo, 2006). The use of antipsychotic medication implies that a 
neurobiological problem needs to be rectified or countered, with one of the major 
areas in neurobiological research focusing on the genetic component of mental illness. 
The role that genetics play in the likelihood that an individual could develop 
schizophrenia has been reported as massive, with a monozygotic twin having, on 
average, an almost 50 percent chance of developing schizophrenia, should the other 
twin be affected by the disorder (Barlow & Durand, 2005; Gottesman & Shields, 
1976; Kendler, 1993;). Ross (2006) attacks Kendler, a lifetime achievement award 
winner for his work in the field of schizophrenia, for his statement that the genetic 
influence in the development of schizophrenia completely overshadows all other 
possible factors. Kendler supports his claim with findings from his own research that 
indicates a 31 percent rate of concordance for schizophrenia in monozygotic twins, a 
figure that actually points to the environment, rather than genetics, playing a bigger 
role (Kendler, 1993 In Ross, 2006). Ross goes as far as stating that, based on 
evidence, it is a scientific fact that schizophrenia is principally caused by 
environmental factors (Ross, 2006). It is also important to be aware of the fact that, 
before any of the literature that provide empirical evidence for the role of genetics in 
the development of schizophrenia existed, in 1899, Kraepelin, the discoverer of the 
constellation of symptoms then referred to as dementia praecox, believed and claimed 
that an inherited predisposition played the most significant role in the development of 
schizophrenia (Boyle, 1990). Others argue that the relationship between genetics and 
environment is better understood when described in terms of the genetic control over 
and individual’s sensitivity to the environment, and the environment’s control over 
the expression of the gene (Tienari, Wynne, Sorri, Lathi, Laksy, & Moring et al., 
2004). These are but a few examples of the large debate surrounding the respective 
effects of environment and genetics on the aetiology of schizophrenia. There are those 
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who might even insist that it has become so incontestable that the behavior of humans 
is regulated by interactions between the social environment and genetic makeup that 
the ‘nature-nurture’ debate is of historical significance only (Read & Hammersley, 
2006). While it is not within the scope of this paper to get involved in this debate, 
Geekie and Read (2008) contend that the dispute over the nature of schizophrenia 
amounts to the very meaning of the term schizophrenia. An example of the effect of 
viewing a disorder in an exclusively specific way, is the recent uncovering that close 
to 60 percent of psychiatric inpatients in Israel are Holocaust survivors, and that, for 
half a century, the majority of them have been diagnosed as suffering from the 
‘genetically-based disorder schizophrenia’, and, with the effects of trauma being 
completely ignored, have been treated correspondingly (Read & Masson, 2004). 
Inquiring about abuse histories and traumatic events in patients suffering from 
schizophrenia is essential, as contextualizing the patient’s symptoms and experiences 
could dramatically change the way that they are viewed and treated (Janssen, 
Krabbendam, Bak, Hanssen, Vollebergh, & de Graaf et al. 2004). It has also been 
argued that the environment and traumatic events can alter the neurology and 
structure of the brain, which could play a vital role in the development, presentation, 
and outcome of schizophrenia (Read, Perry, Moskowitz, & Connolly, 2001). 
For a very long time, from an international perspective, the use of antipsychotic 
medication in the treatment of schizophrenia has been viewed as the most decisive 
element of treatment (Alanen et al., 2009). The efficacy of these antipsychotic 
interventions is regarded by many as supporting evidence that schizophrenia is in fact 
the result of neural-chemical imbalances (Nemade & Dombeck, 2009). Strong 
evidence exists both for, and against this efficacy, and one can be selective in 
choosing a study, as well as the way that the results are presented, to support or refute 
either side. To refute it, the reader is referred to a study done by Arvantis and Miller 
(1997) involving 361 individuals suffering from schizophrenia, from 26 centers in 
North America participating in a randomized, double-blind, prospective, placebo-
controlled trial of the atypical antipsychotic quetiapine, otherwise referred to as 
Serequel. The average reduction in score on the Brief Psychotic Rating Scale (BPRS) 
per participant receiving a dose of 150gm of Serequel was 19.1 percent, with average 
scores falling from 47.2 to 38.2 (Arvantis & Miller, 1997). Attaining a score of 38.2 
on the BPRS is still within the range of severe psychosis, and higher than the score of 
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27 that was used as a cut-off mark for inclusion in the study (Arvantis & Miller, 
1997). Conversely, in support of the claim of efficacy the reader is referred to the 
same study by Arvantis and Miller (1997) as it is described by Kasper and Muller-
Spahn (2000). Kasper and Muller-Spahn (2000) state that Serequel is at least as 
effective as other antipsychotics such as chlorpromazine and haloperidol, and that it 
demonstrates long-term efficacy in the relief of both positive and negative symptoms 
in acute-phase schizophrenic psychosis (Kasper & Muller-Spahn, 2000). They 
substantiate these claims by showing a 40 percent or greater reduction in BPRS scores 
compared to subjects who received the placebo (Kasper & Muller-Spahn, 2000). The 
mere existence of bodies of information that, depending on how the data is presented, 
substantiates or negates claims that heavily influence treatment policy, supports the 
view that the treatment of psychosis is a highly complex affair. The complexity is in 
part a result of the diverse range of stakeholders where treatment is concerned, 
including: the government, pharmaceutical companies, clinicians, patients, and 
patients’ families/caregivers, as well as personal and social factors relating to the 
patient, such as ethnic and cultural background, level of intelligence, substance use, 
trauma history, developmental stage, socioeconomic class, academic level, and 
duration of untreated psychosis (Miller, McCormack, & Sevy, 2008). This complexity 
further lends weight to the importance of the questions that this study aims to answer 
in order to shed light on the elements that are currently influencing the treatment of 
schizophrenia in South Africa. The results of studies are, however, clearly not the 
only factors that are part of the debate. Many studies that aim to prove the positive 
effects of antipsychotics are attacked for a multitude of reasons including; the lack of 
methodological rigor, researchers generating hypotheses that are implausible, the 
publishing of data obtained from the subgroup exclusively, or the viewing of effects 
as artifacts (Irwin, 2004). In 2004, Irwin did a review of all the available studies of the 
antipsychotic chlorpromazine that met the criteria of being randomized, placebo 
controlled, and including individuals with a history of no contact with antipsychotic 
medication that had a minimum of one year of follow-up. Only three studies met the 
criteria (Irwin, 2004). Bola (2006), in a meta-analytic review of the effects of 
medication-free research in early-episode schizophrenia, states that the most 
noticeable finding in his review is the paucity of high-quality evidence that compares 
the long-term effects of initial treatment with antipsychotics compared with short-
term medication postponement in early episode schizophrenia research. One could 
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certainly argue that these findings draw into question the myriad claims that these 
widely used antipsychotics are well-researched forms of treatment for schizophrenia 
(Bola, 2006; Irwin, 2004).  
The arguments against the use of antipsychotics also include the following themes; 
high cost, adverse side effects (including metabolic side effects), clinicians ignoring 
psychosocial factors when administering medication, patient autonomy and decision-
making rights, clinicians being too heavily focused on treatment rather than 
prevention, treatments that are not conceptually linked to the problem, non-medical 
justifications for the promotion of antipsychotics, the over-prescription of drugs, 
extrapyramidal side effects, lowered life expectancy, restlessness, obesity, sexual 
dysfunction, drowsiness, weight gain, and a higher incidence of cardiac arrhythmias. 
Treatment resistance and noncompliance are also important issues that need to be 
taken into account, with an estimated 20 to 40 percent of patients showing marked 
resistance to these drugs, and noncompliance with conventional antipsychotics 
approximated to be between 41 and 55 percent (Fenton, Blyler, & Heinssen, 1997; 
Hellewel, 1999).  
The body of evidence that supports the efficacy of antipsychotics is massive, as is the 
body of evidence that addresses the negative effects associated with this approach. 
Clearly there are serious issues that need to be addressed, some of which could 
possibly be solved with the supplementation of antipsychotic treatment with 
psychological interventions. Although promising, the literature suggests that a 
substantial amount of research needs to be done before enough is known about the 
effects of psychological intervention to allow this approach to be recommended. 
Ultimately it is about finding a balance, and meeting the specific needs of the patients 
(Alanen, 1997). The fact remains that current treatment guidelines only advocate the 
use of psychological interventions for schizophrenia patients in the stable phase 
(APA, 2009). The psychological interventions that are mentioned are done so in a 
very brief and narrow manner, with an absence of supporting evidence for their 
efficacy given as the reason for this (Lehman & Steinwachs, 1998a). The researcher 
does, however, want to make it very clear that the problems associated with 
antipsychotic-use sited in this paper do not form part of an argument that goes against 
the use of said medication. There are problems inherent in all forms of intervention in 
schizophrenia, and the combination of the right treatment elements that cater for a 
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specific individual’s needs remains an incredibly complex task. It is therefore crucial 
to attempt to remain objective in the search for the most beneficial relationship 
between different treatment elements that supplement each other in a way that 
compensates for respective flaws, and optimally treats the patient suffering from 
schizophrenia. The way that South African psychiatrists view this relationship 
remains unclear, and, since these factors play a large and important role in the 
treatment of psychosis, is in urgent need of clarification. 
 
4.6.) Alternative Models of Intervention in Acute-Phase Schizophrenic Psychosis 
The treatment of acute-phase schizophrenic psychosis can never be an either/or 
endeavor. The literature clearly indicates that there are a myriad of psychological and 
biological factors that need to be taken into account to ensure comprehensive 
treatment for a specific individual under specific circumstances. Alanen (1997), as 
well as Bola et al. (2009) advocate treatment that is patient-specific, which implies 
that the treatment approach is, or should be, constantly evolving. When considering 
reasons for the withholding of antipsychotics from patients suffering from acute-phase 
schizophrenic psychosis, Belleza et al. (1978) cite the rationale presented by Boisen 
(1942) which states that an individual suffering from an acute schizophrenic episode 
is faced with a specific problem that must be solved, and that there is an attempt to 
reconstruct their situation which may or may not succeed. A team led by Carl Rogers 
made a similar argument stating that the use of antipsychotics has a negative effect on 
the patients’ emotions, hindering an awareness of their situation, thus making 
psychological intervention less effective (Rogers, Gendlin, Kiesler, & Traux, 1967). 
This concept relates to the ‘developmental crises’ notion that it is possible to 
experience growth from psychosis (Perry 1974 In Bola & Mosher, 2003). Belleza et 
al. (1978) adds:  
In order to solve the basic problem of living, the acute schizophrenic 
needs to attain his sensitivity and awareness and must have full access 
to all his psychological resources. Phenothiazines, by reducing 
neurological sensitivity, may interfere with these problem solving, 
reintegrative responses (p.107).    
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This is directly related to the issues of purpose of treatment. If the purpose of 
treatment is to provide the context for psychological intervention, antipsychotics that 
impede on higher cognitive processes used for problem solving could prove 
unproductive (Bola & Mosher, 2003). If, however, the purpose of pharmacological 
intervention is to keep a psychotic patient from behaving violently, harming him or 
herself, or from committing suicide, the use of antipsychotics seems warranted 
irrespective of possible neurological effects that could hinder thinking processes 
(Hughes, 1999). Ultimately the purpose of treatment should be to meet the needs of 
the patient, however complex this might be (Alanen, 1997).  
The Soteria model of intervention is put forward as an alternative to over-reliance on 
antipsychotics, and is based on the work of Loren Mosher who viewed psychosis as 
“a coping mechanism and a response to years of various events that were subjectively 
experienced as traumatic and led the person to retreat from reality” (Aderhol, 2009, 
p.329). The model’s original objective is to determine whether a specifically designed 
intensive psychological treatment, based on a relationship-focused approach that 
incorporates the minimal use of antipsychotics over a period of 6 weeks, will produce 
equivalent or better outcomes in the treatment of newly diagnosed schizophrenic 
patients when compared to ‘traditional’ hospital psychiatric ward treatments that rely 
exclusively on antipsychotics (Bola & Mosher, 2003). During the development of the 
Soteria approach to treatment, in addition to the aim of minimizing the use of 
antipsychotics, the approach was supplemented with the following three concepts:  
…the recognition of significant rates of recovery without drug treatment in 
early episode psychosis; the observation that many patients do not benefit 
from medications (through drug treatment resistance and noncompliance); 
and a valuing of interpersonal care and treatment of mentally ill patients 
(Bola & Mosher, 2003, p. 220).  
According to Bola and Mosher (2003) the Soteria model of treatment incorporates “a 
small, homelike, intensive, interpersonally focused therapeutic milieu with a 
nonprofessional staff that expected recovery and related to clients in a manner that did 
not invalidate their experiences of psychosis” (p. 221). The treatment components 
utilized in this approach include: milieu, which was characterized by support, 
spontaneity, and involvement; attitudes, especially those of Soteria staff, who expected 
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positive change in patients, and were seen as more introverted, tolerant, and flexible 
than the average hospital staff members; therapeutic relationships, which was seen as 
one of the key therapeutic factors of the Soteria model and acted as the context for 
staff to understand patients’ subjective experiences of psychosis, and which functioned 
as a guide toward social reintegration; social networks providing support and helping 
patients buffer stress, were implemented by providing the patient with a surrogate 
family that helped him/her with social reintegration; cultural factors also played a role 
leading to comparisons made between the positive effect on outcome that the social 
climate of the Soteria model has, with the cultural influence of social interaction on 
the outcome of schizophrenia in developing countries as documented by the World 
Health Organization (Bola & Mosher, 2003) and other studies (Irwin, 2004). The rates 
of recovery without the use of antipsychotics are reported as significant, in particular 
for those individuals suffering from early episode psychosis (Bola & Mosher, 2003). 
There clearly are significant differences in treatment approach when comparing 
conventional use of antipsychotics to combined minimal medication and psychosocial 
interventions in schizophrenia. It is, however, difficult to determine the specifics of 
these differences with regard to exact dosage used in each situation, and formalized 
models of implementation. The literature is vague on these points, and, in some cases, 
makes these alternative treatment approaches seem more like on-the-spot 
improvisation than evidence-based intervention, which is, as has been shown, one of 
the main arguments against the implementation of psychological interventions in 
schizophrenia (Lehman & Steinwachs, 1998a). The comparison made between 
conventional and alternative interventions in schizophrenia focuses primarily on the 
different treatment milieus in the respective approaches, and argue that it is precisely 
the differences in setting, staff attitude, and approach that warrants the discarding of 
psychopharmacological interventions  (Mosher & Vallone, 1992). Five categories 
were identified that made the experimental setting significantly different from the 
control setting (representing standard hospital settings): approaches to social control 
that avoided codified rules, regulations, and policies; keeping basic administrative 
work to a minimum so as to allow a great deal of undifferentiated time; limiting 
intrusion into setting; working out social order on a face-to-face emergent basis; and 
commitment to a non-medical model that did not require symptom suppression. 
Unfortunately the literature does not provide the exact details of how these differences 
are established, regulated, and maintained. In a final review of the effects of the 
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Soteria approach, Mosher and Vallone (1992) state that they expected the long-term 
effects of psychosocial interventions to mirror those of conventional antipsychotic use, 
which, seemingly, was the case. What surprised them was the fact that they found the 
control group exposed to antipsychotics changed markedly less during the initial six 
week period compared to patients in the group not exposed to antipsychotics (Mosher 
& Vallone, 1992). Mosher & Vallone (1992) reported that these findings are 
contradictory to evidence put forward by pharmaceutical companies, but also stated 
that it is entirely possible that the control group that was treated with antipsychotics 
could have deteriorated even more if left untreated, which could be a reflection on the 
differences in treatment milieu, and the effects of those differences. One factor that is 
very revealing of Mosher and colleagues’ attitudes toward mental illness and its 
causes, is the fact that they explicitly state that individuals who are relatively 
competent (studying, working, successfully living independently) and suffer an acute 
onset of psychosis as a result of life events, should not be treated with antipsychotics 
(Mosher & Vallone, 1992). They do not elaborate on this point, but could not blame 
the reader for inferring that they are leaning toward a primarily psychosocial cause for 
schizophrenia, which could explain their lack of confidence in the use of 
antipsychotics that aim to address imbalances in neurological functioning. The 
definition given of a relatively competent individual also typically precludes the case 
where an individual suffers impairment marked enough to justify a diagnosis of 
schizophrenia. The findings of their study reflect favorably on the absence of 
antipsychotics in the treatment of schizophrenia, but need to be seen in the context of 
the larger debate that includes: different theories regarding the causes and progression 
of schizophrenia; conflicting results of different studies that look at the side effects of 
the same antipsychotics; available resources; and the complex and idiosyncratic 
experience of the individual suffering from schizophrenia. Some of the measures used 
in this Soteria study are, however, oversimplified, and weaken the methodological 
rigor of the study (Mosher & Vallone, 1992). These include measures that look at 
precipitating events that lead to psychosis, as well as measures that determine the 
degree of psychosis experienced by the patient (Mosher & Vallone, 1992). Many of 
the ideals strived for in the Soteria model are psychologically sound, but are, 
unfortunately, contextualized by a lack of specific information in terms of what 
exactly is meant by concepts such as ‘minimal-medication’, ‘psychosis’, ‘non-
professional staff’, and ‘need-based interventions’.  
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The fact is that there exists a large amount of studies that report positive outcomes for 
the use of psychological treatments for schizophrenia in general, as well as for acute-
phase schizophrenic psychosis (Aderhold, 2009; Aderhold & Gottwalz, 2004; Bola, 
2006; Bola et al., 2009; Bola & Mosher, 2003; Calton et al. 2007; Chen & Moreno, 
2006; Dudley & Turkington, 2009; Irwin, 2004; Kanas, 2000; Kennard, 2009; 
Koehler & Silver, 2009; Morrison, 2004; Mosher, 2004; Mosher & Bola, 2004; 
Rogers, Gendlin, Kiesler, & Traux, 1967; Scott & Dixon, 1995; Silver, 2000; Silver et 
al., 2004; Thorgaard & Rosenbaum, 2006). One such study (Rogers et al., 1967) states 
that therapy, compared to the use of antipsychotics, has a superior effect with regard 
to the patient’s ability to: manage interpersonal relationships; decrease emotional 
distance from the events that they related; exhibit appropriate emotional expression; 
and deal with themselves, as well as the world that they inhabit.  
There are, however, those that state that the Soteria model, in spite of its success as 
reported by the abovementioned studies, still needs to be the subject of scientific 
study until there is ample quality evidence indicating that this is a legitimate 
alternative method of treatment for acute-phase schizophrenic psychosis, and that it 
can not, as of yet, be put forward as such an alternative (Calton, Ferriter, Huband, & 
Spandler, 2007). This is also emphasized in the PORT report in which the authors 
state that psychological interventions are no less important than pharmacological 
interventions, but that there simply is not enough quality evidence to support its use 
(Lehman et al., 1998a). Others would argue that the criteria for a legitimate 
intervention method have not exactly been met by approaches that imply the exclusive 
use of antipsychotics either (Bentall, 2009; Bola, 2006; Irwin, 2004). Following the 
establishment of Soteria in 1971, roughly twelve homogenous projects have been 
launched around the globe, the majority of them in Europe (Aderhold, 2009). It is 
theorized that the lack of similar programs in the USA could be due to Mosher’s 
supposed anti-psychiatric inclination, but many hope that the advancement of 
neurobiological research will reveal the ‘antipsychotic’ results of therapeutic 
relationships and stimulating surroundings, and that these will contribute to the 
rationale for the establishment of Soteria programs in the USA and other countries 
(Aderhold, 2009).  
The Soteria approach is, however, but one alternative to the exclusive use of 
antipsychotics. There exists a range of effective evidence-based psychosocial 
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treatments for psychosis that must be made available to all that need it (Read & 
Hamersley, 2006). CBT is among the most researched of the psychological 
approaches, and has been proven effective in many studies. (Dudley, Brabban, & 
Turkington, 2009; Morrison, 2004). Other psychosocial interventions that are also put 
forward as treatments for schizophrenia and acute-phase schizophrenic psychosis are: 
family therapy (Aderhold & Gottwalz, 2004); psychodynamic psychotherapy (Silver, 
Koehler, & Karon, 2004); and group therapy as an integrated approach (Kanas, 2002). 
A more in-depth look at these alternatives is, however, beyond the scope of this paper. 
The matter of the ethical implications related to the withholding of antipsychotic 
treatment is another issue that forms part of the battle for psychological interventions 
to be recognized as legitimate. This issue is addressed in a meta-analytic review that 
did not find any indications of long-term harm from short-term medication 
postponement in acute-phase schizophrenic psychosis (Bola, 2006). To ensure the 
ethical adequacy of medication-free research, Bola (In Chen & Moreno, 2006) 
suggests applying the ‘middle ground’ approach of Emanuel and Miller (2001). The 
middle ground approach utilizes three criteria for the assessment of individual 
research protocols to guarantee that the brief medication-free periods are ethically 
acceptable (Chen & Moreno, 2006). The three criteria are: 1.) A conclusive scientific 
argument provides grounds for the study and its design; 2.) Respondents that 
experience intentional trial-related medication-free periods should not be markedly 
more likely than those in the active-treatment group to die, to suffer any other harm 
including disability or permanent morbidity, to suffer non-permanent yet serious 
harm, or to endure grave discomfort; and lastly, 3.) Studies that meet the respective 
ethical and methodological criteria, are still required to implement precautions to 
minimize the risk of harm (Chen & Moreno, 2006). Bola et al. (2009) state that the 
ethical conduction of medication-free research allows for the exploration of numerous 
scientific questions, including: 
…the comparison of new medications to placebo; minimum dosage 
requirements and dose-response predictors; whether the minimum dose 
of medication includes zero; developing the role of psychosocial acute 
treatment in the therapeutic armamentarium; identifying patients with 
spontaneous remission or less serious forms of psychotic disorder (e.g. 
schizophreniform disorder) and which distinct treatments they should 
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receive; how to estimate effect size for the components of treatment 
(apart from the combined effect of many treatments); and what the 
predictors of patient responsiveness to different treatment components 
are (p.5).  
The contribution to knowledge that medication-free research stands to make, lends 
strong support to its implementation. This includes: a more homogeneous sub-
grouping of early-episode patients; enhanced patient outcomes; a more sophisticated 
utilization of the medical model; and a decrease in measurement-error in the analysis 
of the causal factors underlying the subtypes of psychotic disorders (Bola et al., 
2009).  
One can argue that the specific types of psychotherapy that could be used to treat 
acute-phase schizophrenic psychosis in South Africa are far from being established in 
terms of official guidelines. In a paper termed ‘Integrating Approaches to 
Psychotherapy in Psychosis’ Margison and Davenport (2008) argue for the 
consolidation of different psychological perspectives in the treatment of psychosis. 
Interestingly, they also state that integration is significantly easier on a practical level 
than on theoretical level (Margison & Davenport, 2008). Unfortunately the literature 
suggests that the current treatment climate in South Africa does not leave a great deal 
of room for the practical development and integration of psychological interventions 
in the treatment of acute-phase schizophrenic psychosis. What is happening in reality, 
however, and what is possible, could be a different matter altogether. The 
authoritative role that psychiatrists have in leading treatment decisions in psychiatric 
settings in South Africa, makes them the group with the richest body of information 
regarding which interventions in schizophrenia work, which do not, and why, which 






5.) RESEARCH QUESTIONS 
 
• What is the knowledge that South African psychiatrists have of combined 
minimal medication and psychosocial interventions in acute-phase 
schizophrenic psychosis? 
• What are the attitudes that South African psychiatrists have toward combined 
minimal medication and psychosocial interventions in actue-phase 
schizophrenic psychosis? 
• What are the preferred practices of South African psychiatrists for the 
treatment of acute-phase schizophrenic psychosis? 
 
6.) RESEARCH METHOD 
 
6.1.) Research Design 
The proposed study has a qualitative design, allowing the researcher to gain 
information of the participant’s experience in the specific subjective context in which 
it is experienced (Willig, 2001). A qualitative design also allows for the study of 
complex areas of health care, such as the treatment of psychosis (Fosey, Harvey, 
McDermott, & Davidson, 2002). Inasmuch as the responses of the research 
participants have a subjective nature, and are not based on simple, objective 
constructs, an interpretive research paradigm was applied (Scwandt, 1994). An 
interpretive paradigm accommodates the subjective nature of the responses as it gives 
importance to the attempt to discover and understand the meanings of an individual’s 
actions and experiences (Fosey et al., 2002). It also emphasizes the importance of 
providing accounts of these meanings from the perspectives of those involved (Fosey 
et al., 2002). Semi-structured interviews with psychiatrists in Johannesburg were used 
in an attempt to determine their knowledge, attitudes, and preferred methods of 
treatment regarding minimal medication interventions in acute phase schizophrenic 
psychosis. Multiple data gathering techniques, such as triangulation, were not used 
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(Fosey et al., 2002). The use of interviews exclusively allowed the researcher to 
obtain sufficient information to answer the research questions, as the information was 
obtained directly from the group on which the research questions focus. A cross-
sectional method was used instead of a longitudinal method. The participants were 
interviewed only once, since the researcher is interested in the participants’ 
knowledge, attitudes, and practices, with regard to minimal medication interventions 
in acute-phase schizophrenic psychosis as it stands at the time of interview, and not if, 
or how, these constructs develop over time (Howell, 1997). 
 
6.2.) Procedure 
The researcher telephonically contacted psychiatrists working in hospital in-patient 
settings in Johannesburg, South Africa. The nature of the research, as well as its 
purpose, was explained to the psychiatrists, with a subsequent request for their 
participation made by the researcher. In addition to the telephone call, an information 
sheet containing the contact details of the researcher, the details of the research, and 
the research procedure as it involves the participant, was e-mailed to the psychiatrists. 
E-mails were sent to psychiatrists who could not be reached telephonically. The 
content of the e-mail resembled that of the telephone conversation. A purposive 
sample of 8 participants was selected from different hospital in-patient settings in 
Johannesburg. The researcher administered a self-designed semi-structured 
questionnaire in face-to-face interviews with all 8 participants. The questionnaire, 
which can be viewed in Appendix D, contained a maximum number of 8 questions, 
all of which were probed further, which allowed the researcher to obtain in-depth 
information. The participants were all interviewed at the hospital where they currently 
work. The researcher obtained informed consent from all the participants in order to 
allow their participation. The researcher was of aware his professional background, 
and acted to control for it as it could have resulted in preconceptions when conducting 
the interview, which could have influenced the formulation of the questions, as well 
as the researcher’s responses to the participant’s answers (Coar & Sim, 2009). Further 
consent was obtained to allow for the digital recording of the interviews, and the 
subsequent transcription thereof. Confidentiality is maintained through the use of 
pseudonyms, and no personal information that could lead to the identification of 
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participants is included in the research report. Some direct quotations are included in 
the report to substantiate an argument, or highlight a point. Although this implies the 
verbatim account of the interviewee’s responses, all personal information that could 
lead to identification is either omitted or altered. A debriefing was not done, as the 
interview did not touch on any personal sensitive issues. Thematic content analysis 
was used to analyze the transcribed material, and is explained in detail in the analysis 
section. As per the Health Professions Counsel of South Africa’s guidelines the 
recorded material will be destroyed a minimum of 2 years after publication, or after a 
minimum of 6 years if not published.   
 
6.3.) Participants 
The researcher has chosen to conveniently sample Johannesburg, as easy access to 
psychiatrists was available (Howell, 1997). Psychiatrists working in hospital in-
patient settings in Johannesburg were purposively sampled, with the exclusion of 
psychiatrists in private practice, to promote a relatively homogenous practice 
environment amongst participants. Another requirement for admission to the study 
was that participants needed to be currently employed in a hospital in-patient setting, 
or need to have been a full-time employee in such a setting in the last three years. This 
was a non-random sample that ensured that the researcher could survey the behavior 
and experiences of the specific group, yielding information that will be more valuable 
than information obtained from a random group of individuals (McBurney, 2000). As 
is the nature of qualitative research based on interview, the researcher aimed to 
permeate social reality beyond the explicit meanings as presented by participants 
(Crouch, 2006). Thus, seeing that the researcher aimed to do an in-depth inquiry into 
the naturalistic environment of practicing psychiatrists in South Africa, a small 
sample was warranted (Crouch, 2006). Consequently, a purposive sample of eight 
psychiatrists working in hospital in-patient settings in Johannesburg were interviewed 
to obtain saturated data that is in-depth and rich enough to support the study. 
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6.4.) Data Collection Tool 
A self-designed semi-structured questionnaire consisting of a maximum of 8 
questions was administered by the researcher in face-to-face interviews. The use of 
semi-structured interviews is warranted as it allowed for a flexible interview with a 
conversational style (Whitley, 2002). This is advantageous when dealing with the 
participants’ subjective experiences and attitudes, as it does not force them to answer 
in a specific format, and enables participants to relate their experiences of dealing 
with acute-phase schizophrenic psychosis in a way that reflects their own reality 
(Whitley, 2002). Semi-structured interviews also enabled the researcher to employ 
open-ended questions to allow for probing, which placed the researcher in a position 
to procure an increased understanding and richer information (Reja, Manfreda, 
Hlebec, & Vehobar, 2003). Although these questions could have been answered by 
doing a survey, and many more psychiatrists could be reached in this way, time 
constraints lead the researcher to choose a qualitative approach. Previous studies 
conducted within university research projects using questionnaires, have been met 
with very poor response rates when trying to recruit psychiatrists as participants. This 
drastically hindered the successful completion of the research. Interviews with a 
relatively small sample also allowed the researcher to gain a more informed view of 
the participants’ reality, and yielded information that is more in-depth and richer in 
nature (Crouch, 2006). The questions were set in three main categories that focus on 
the participants’ knowledge, attitudes, and practices as they relate to the combined 
minimal medication and psychosocial interventions in acute-phase schizophrenic 
psychosis. The researcher was aware of the fact that the interview constitutes a social 
situation, and that reflexivity possibly played a role (Coar & Sim, 2009). This means 
that the responses that the participants produced may be conditioned by the wider 
professional and social context of the interviews (Coar & Sim, 2009). This includes 
the participant’s own agenda, his/her desire to maintain his/her professional identity, 
and his/her interpretation of the role that the interviewer fulfills (Coar & Sim, 2009). 
The researcher took these elements into account by keeping a journal of relevant 
factors and being mindful of the effect that he had on the interview process. 
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6.5.) Data Analysis 
After the interviews were digitally recorded, they were transcribed verbatim. 
Thematic content analysis was used in the identification of patterns and central 
themes (Coffey & Atkinson, 1996). More specifically, the analysis approach of Potter 
and Wetherell (1987) was used, and the researcher was mindful that the participants’ 
responses could have been influenced by their view of the objective of the interview. 
The researcher gathered sections of text under broad categories, and added provisional 
categories, after which these categories were refined in the search for emerging 
themes (Boyatzis, 1998). These themes made the large quantity of in-depth 
information that interview studies typically yield more manageable.  The next step 
was coding the data in order to link relevant responses to the determined themes, and 
to compare the responses (Boyatzis, 1998). After the data was coded and sorted into 
relevant themes, and was reduced to a manageable size, the researcher familiarized 
himself with the data. This entailed the meticulous reading of the data to identify the 
main themes, which lead to the focusing of the data (Sarantakos, 1998). The final step 
in the analysis process was the interpretation of the data. The researcher was fully 
aware of the fact that both the quality and the authenticity of the research are greatly 
affected by the extent to which interpretations are made from the information gathered 
(Fosey et al., 2002). In accordance with this the researcher aimed to maintain 
awareness of the possible effects that external and personal factors could have had on 
the interpretation of the responses. These effects were also included in the data 
analysis section to improve the transparency of the research process (Oliver, 2004). 
To avoid ‘conceptual blindness’, the researcher took care not to allow his familiarity 
with the area of study to dominate the process of data analysis (Coar & Sim, 2009). 
This also helped to ensure that the acquisition of novel insights remained possible 




Since there are clearly many different and opposing schools of thought with respect to 
the treatment of schizophrenia, the researcher was careful not to put participants into a 
difficult position by making them feel that they should advocate a specific approach 
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to treatment. The researcher’s responses to the participants’ answers were given 
carefully, ensuring that the participants did not feel evaluated or judged. The 
researcher also took care not to place the participants in an exam-like situation in 
which they could feel that their knowledge was being tested (Coar & Sim, 2009). This 
could, however, have happened despite the fact that the interviewer was looking for 
conceptual understanding of alternative methods of treatment in acute-phase 
schizophrenic psychosis, rather than a factual understanding (Coar & Sim, 2009). 
Thus, from the outset, the researcher informed the participants of this fact, and 
explained that there are no wrong or right answers. It was also stated clearly that no 
preparation would be necessary prior to the interview. This also allowed the 
participants to maintain their professional identity (Coar & Sim, 2009). 
With regard to issues of confidentiality, participants might not want their opinions 
made public. Thus, an agreed upon alias was used during transcription. Issues of 
confidentiality have been more thoroughly addressed in the ‘procedure’ section. 
Participants obtained a signed copy of the consent form ensuring the confidentiality of 
the material. The recorded and transcribed data is kept in a secure location, with only 
the researcher and his supervisor having access. Since the researcher is aware of the 
participants’ personal information, anonymity cannot be preserved. The informed 
consent form also contains the contact details of the researcher, should participants 
have any questions or concerns. 
It is extremely difficult to conduct research separately from its political, 
administrative, legal, and economic considerations.  Thus it is important for 
researchers to adhere to a code of conduct where research is concerned, especially 
where human participants are involved. Included in this code of conduct is the 
researcher’s duty to ensure that all participants are completely informed. 
To ensure this, the researcher followed these guidelines provided by Fink and 
Kosecoff (1998): 
• Give a fair explanation of the procedures to be followed and their purposes. 
• Provide a description of any risks and benefits.  
• Offer to answer any inquiries.  
• Provide the instruction that the participant is free to withdraw consent and to 




Thematic content analysis was used to identify themes as they emerged in the 
interviews. Themes have been selected based on their relevance to the literature, the 
frequency of responses, and the focus of the study. These themes have been grouped 
under the headings Knowledge, Attitudes, and Practices, which was also the structure 
used to inform the content and layout of the interview schedule. The themes will be 
presented thus, supplemented by relevant quotes from the participants’ answers. The 
interpretation of these themes will follow in the Discussion section.  
 
7.1.) KNOWLEDGE 
This section looks at the themes that correspond to the Knowledge component of the 
participants’ responses. These themes were selected based on the frequency with 
which they occurred in the responses, and their relevance to the participants’ 
knowledge regarding combined minimal medication and psychosocial interventions in 
acute-phase schizophrenic psychosis. 
 
7.1.1.) Problems Related to the Definition of Schizophrenia and its Phases 
The definition of schizophrenia was a contentious issue for some of the participants, 
as the disease manifests in a variety of ways, and has a broad range of symptoms that 
play out in a particular way depending on the profile of the patient.   
Participant 1: Well I would be very interested in knowing what kind of 
schizophrenia patients they treat, um, was it people who were only 
deluded, or did they have predominantly negative features or 
behavioral features? Were they sort of acting out on command 
hallucinations? Because if you go and look at acute-phase 
schizophrenia there is a huge variety of how people can present. 
The matters of the progression of schizophrenia, and the subsequent phases that 
follow were also mentioned as problematic, as the different phases warrant different 
approaches. Even though the researcher defined acute-phase schizophrenic psychosis 
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as an active psychotic state experienced by an individual suffering from 
schizophrenia, some participants still felt that the definition is somewhat unclear.  
Participant 2: I just, getting back to your definition, I would put in 
psychosocial interventions in the acute phase after two weeks, 
depending on the patient. Acute as in the first six months, then 
definitely. It just depends on the definition. 
 
7.1.2.) Participants’ Awareness and Knowledge of Combined Minimal 
Medication and Psychosocial Interventions in Schizophrenia 
More than half (5 out of 8) of the participants were not aware of the existence of 
combined minimal and psychosocial interventions in acute-phase schizophrenic 
psychosis. 
Participant 4: No, not in our circuit that I know of, or wider spread 
either. 
Participant 5: I’m not aware of these projects in terms of these 
patients being psychotic yet, basically I am aware of withholding 
medication in patients in the pre-phase of schizophrenic, the 
prodromal phase, so my answer would be no I am not really aware. 
Less than half (3 out of 8) of the participants were aware of the existence of combined 
minimal and psychosocial interventions in acute-phase schizophrenic psychosis, 
although they did not possess any detailed knowledge regarding the interventions.  
Participant 2: Uh, I think there is the ones in Melbourne, they were 
using lots of psychosocial interventions in Melbourne, and I think 
there’s some in America, so I am aware of some of the projects. The 
one that, in particular early intervention in psychosis is the one in 
Melbourne, but um, I must be honest, I am aware of it, but not in much 
detail. 
Participant 5: I sort of briefly read about them, but not extensively, I 
know that it happens, but my knowledge of it is not very good.  
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7.2.) ATTITUDES 
This section focuses on the Attitudes component of the participants’ responses. The 
sub-themes reflect the different aspects that make up the participants’ attitudes toward 
combined minimal medication and psychosocial interventions in acute-phase 
schizophrenic psychosis.  
 
7.2.1.) Negative Attitudes toward Soteria-Based Models of Intervention 
Participants were given a standardized explanation of what combined minimal 
medication and psychosocial interventions in schizophrenia would look like, in 
particular based on the Soteria approach. This explanation can be viewed in Appendix 
E. More than half (5 out of 8) of the sample stated negative opinions of this model.  
Participant 1: But, in my opinion I would be against it, because we 
know from the literature that untreated psychosis could be detrimental 
to a patient, so we want to try and reduce the psychotic episode to 
lessen the cognitive fallout and things like that, so for me I’m more to 
advocate structure, boundaries, containment, I think the patients do 
well, so from my perspective, those projects I would not be in favor of. 
Participant 4: Very negative, because it is very difficult to predict 
outcome. I think my sort of thought process and focus in terms of 
schizophrenia and psychosis in the acute phase is basically maybe 
three fold, immediate, medium term and long term. Now the most 
concerning for me are the long-term effects of psychosis if left 
untreated. 
Participant 3: I still wouldn’t think much of that kind of approach. We 
are very clear on schizophrenia being a severe biological illness, and 
the psychosocial factors are certainly there in terms of promoting 
relapses and making people remain unwell, but certainly as a 
causative factor on it’s own, and definitely when people are acutely ill, 
to withhold treatment from such people may even be unethical in many 
cases. 
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Participant 5: I think it would have very low value, I cant see such an 
approach being implemented first of all, because I think South African 
research is very much in keeping with international trends in terms of 
etiology and management of schizophrenia being largely biologically 
based with antipsychotics, and then psychosocial interventions being 
adjunct. 
 
7.2.2.) Psychosocial Interventions in Acute-Phase Schizophrenic Psychosis Seen 
as Negligent and Unethical 
More than half (5 out of 8) of the participants stated that they see the withholding of 
medication, and the substitution of medication with psychosocial interventions as 
negligent and unethical. 
Participant 2: Once again I think in the acute-phase schizophrenia 
psychosis psychosocial intervention is much less, or even negligent, 
versus the effect of medication. 
Participant 3: The first thing is that ethically I don’t know how one 
can get clearance for that, it’s almost as though one is doing a placebo 
trial, you know that leaving the person psychotic is dangerous to them 
for a number of reasons, and you have treatment available that is 
helpful and you are not using that, so ethically I have a problem with 
those kind of studies. 
Participant 6: We are very clear on schizophrenia being a very severe 
biological illness, and the psychosocial factors are certainly there in 
terms of promoting relapses and making people remain unwell, but 
certainly as a causative factor on it’s own, and definitely when people 
are acutely ill, to withhold treatment from such people may even be 
unethical in many cases. 
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7.2.3.) Psychosocial Interventions only Indicated for ‘Soft’ Psychosis 
Half of the participants made it clear that psychosocial interventions are indicated 
only in cases of softer psychosis, in particular where the patient does not exhibit 
severe behavioral problems, or poses as significant danger to themselves or others.  
Participant 1: Ja, you have to remember, that X is a psychiatric 
hospital. We receive the people that are really bad, I mean they have 
to be made involuntary after they arrive. So they are at the extremes of 
the spectrum, and um, like I say I don’t believe that the ones that we 
receive acutely are in any way, I think that they would be considered 
dangerous for people to work with, they are quite irritable, the 
schizophrenia, they may lash out, and I must say that I don’t have the 
experience that in the acute psychotic phase that any kind of 
psychological intervention helps them. 
Participant 3: You know it’s difficult to say, probably there is a 
broader aspect of what is the acute phase, I mean patients we see here 
at Y often are not just psychotic but are aggressive, and have behavior 
problems. But often there are just the deluded, that don’t have any 
aggressive behavior problems, and they might be sort of, more suitable 
for psychological intervention. 
Participant 4: However, schizophrenic is too heterogeneous, it is a 
very broad disorder, either spectrum you may get very different 
patients with very different symptoms, in terms of behavior control and 
aggression, secondary to the psychosis, it is very risky I would say, but 
that is sort of a very bird’s-eye view, from my point of view.  
 
7.2.4.) Psychosocial Interventions in Schizophrenia Viewed as Supportive Only 
All of the participants stated that they see psychosocial interventions, and approaches 
that involve the delay of medication as supportive only, and that these models of 
interventions need to be viewed as adjunct if indicated, and not as primary 
interventions.  
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Participant 1: I don’t think their brains are quite organized enough to 
work with therapy, um, socially, um, yes I think that, maybe in a 
supportive role, but those would be essentially for mood related 
issues… Other than supportive I don’t see, I don’t generally offer 
psychologists in the ward in the acute phase. 
Participant 2: So the psychological would be family therapy, um, sorry 
I don’t know if I’m answering the question right, family intervention as 
in supportive psychotherapy... For the patient could be supportive, um, 
you know looking at the impact of the social as part of the illness, so 
very different from what you are describing. It is more supplementary, 
and thereafter to bring in alternative interventions, thereafter I am all 
for insight orientated therapy, CBT or whatever, but, my first and 
foremost is medication. 
Participant 5: Mostly acute phase schizophrenia the psychologists 
don’t get involved, it’s a bit later, unless it’s the family, we get the 
family involved to try and understand what is going on, so only in 
terms of social circumstances. 
Participant 7: That does not say that we are not doing individual 
therapy, it is definitely there too, primarily on a constant interview 
basis, getting collateral, making them part of family therapy, is most 
definitely part of it.  
Participant 8: In terms of their being a role, it certainly would not be 
the pivotal role or the dominant role, it would be more supplementary, 
in terms of interaction with the patient, getting them to trust you, and 
longer term with compliance with... and that is not to treat psychosis, 
but to treat the impact that the psychosis is having on the individual, 
which is actually part and parcel of the management of that individual.  
Most of the participants (7 out of 8) supplemented this view with their understanding 
that the effect on a patient suffering from schizophrenia renders them incapable of 
making use of psychotherapeutic interventions. 
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Participant 1: I don’t think their brains are quite organized enough to 
work with therapy. 
Participant 5: At this moment I must say I don’t think there is a role 
for a psychological intervention in someone who is acutely psychotic, 
um, because of the patient’s psychosis, be it their thought content or 
their thought disorder, there is actually no role for it in the acute 
phase. 
Participant 6: Now psychosocial interventions in the acutely psychotic 
person it is very difficult because we don’t view them as having 
enough sort of insight into understanding psychological processes. In 
our mind the basis for psychosis is, there is disturbed understanding of 
reality and self. 
Participant 8: Well I don’t think it is going to be very helpful when the 
patient is psychotic. You can’t talk to them cause they don’t have any 
sense. The psychologists say that it is no use to talk to them… These 
are psychotic people, they are out of touch with reality, I would leave 
them on the medication.  
 
7.2.5.) Negative Attitudes Toward Psychodynamic Interventions in 
Schizophrenia 
When participants were probed in terms of specific psychosocial or psychological 
interventions that they would not be willing to implement, 7 out of 8 stated that they 
would not be willing to implement any form of psychodynamic psychotherapy when 
treating acutely psychotic patients suffering from schizophrenia.  
Participant 1: Whilst I do believe that the delusions can serve some 
kind of psychological purpose, um, I don’t believe that there’s a role in 
the initial phase, um, in fact, I dealt with a patient that was 
psychotherapised in the initial phases, and it actually worsened his 
psychosis significantly, and kind of created a whole new set of sexually 
inappropriate delusions. I have to say that that was done with 
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psychodynamic therapy, which I think we all know is not appropriate 
to it... But my general experience is that it becomes too abstract for the 
schizophrenic to deal with. 
Participant 2: I don’t think it has a place to be honest, I would go 
more supportive, maybe CBT, but I would definitely not go with 
psychodynamic psychotherapy. Patients not in touch with reality, they 
are agitated and irritable, they can’t reflect, but that’s why I say 
possibly a CBT approaches for the here-and-now, and the delusion, 
uh, but not psychodynamic, definitely not psychodynamic. 
Participant 5: Well it may reflect more my experience and my 
knowledge base of what the relevant treatment for a condition like 
schizophrenia is, and it doesn’t include psychodynamic therapy, you 
know I have seen patients who can completely regress with 
psychodynamic psychotherapy, but when you are dealing with a 
psychotic patient you already have someone where ego boundaries are 
tenuous, where reality testing is impaired, and to use a psychodynamic 
approach can be even dangerous. 
It should also be noted that the respondent who did not state negative opinions toward 
a psychodynamic approach, did not state any favorable opinions toward it either, and 
failed to mention it in its entirety.  
 
7.2.6.) Cognitive Behavioral Therapy Indicated for the Treatment of 
Schizophrenia 
The majority of participants (5 out of 8) indicated that they are in favor of Cognitive 
Behavioral Therapeutic (CBT) interventions in the treatment of schizophrenia, 
although this method of intervention was also indicated as a secondary adjunct to 
medication. 
Participant 3: Well, like we all know Cognitive Behavioral Therapy 
has been proven beneficial. One would obviously have to establish if 
the person has the cognitive abilities before you start. 
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Participant 4: If they are acutely psychotic what I generally find is 
that, if the delusions are not shifting, then you could use maybe a CBT 
approach in the acute phase, then yes there’s a place, maybe 
challenge the delusions, but, I think in the acute phase it’s more 
support. 
Participant 6: Um again I think I am kind of showing my concrete 
nature, that it is about what is possible, that CBT generally is time-
limited, where psychodynamic is rather more intensive and long-term. 
 
7.2.7.) Psychosocial Interventions in Schizophrenia Not Viable in South Africa 
Most participants (7 out of 8) indicated that they do not think that combined minimal 
medication and psychosocial interventions in schizophrenia are viable in South 
Africa, as the current health-care system simply does not have the necessary resources 
available.  
Participant 1: I don’t think it would be viable. I mean first of all to get 
minimal, in terms of the South African health-care system, at present 
we don’t even have enough in terms of the structured facilities, homes, 
rehab centers. So for something that is so, in terms of very little 
literature, and very little evidence based, I would not waste my 
resources. 
Participant 3: We are struggling to get patients that have been fully 
medicated and with some level of psychotherapy in our wards out into 
the community and keep them stable with the current resources. It 
sounds like these projects needs lots of fairly intense and trained 
people, and you need high numbers of these environments. It could be 
fairly difficult if it is state-run, based on what I know of the state’s 
mental institutions, and what I know of the district psychiatric 
services. It seems to be fairly under-funded and under-staffed, and um, 
very difficult to track psychiatric patients because of the nature of 
their illness in general. 
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Participant 7: And that is again based on elements that we have to 
take into consideration, um, like resources, that once again does not 
say that you are not going to do psychosocial, but just to think how we 
are going to do it with one, personally I don’t think, not viable. 
 
7.2.8.) The Importance of a Biopsychosocial Approach to Treatment 
Half of the participants stated the importance of a biopsychosocial approach to the 
treatment of schizophrenia. These participants made it clear that linear approaches to 
the treatment of the disorder will fail, as they do not address the vast range of needs 
that these patients have. 
Participant 1: I think psychological is very important, because I think 
you know, giving someone a diagnosis of schizophrenia has major 
implications, and I think the patient needs a lot of support, 
understanding, insight into the condition and, also um, you got to give, 
remember that the high emotional state increases their risk of relapse, 
so you need to contain the patient in psychotherapy in long-term, it’s 
vital for a patient with schizophrenia, because you want to reduce 
their stress. So they need therapy. 
Participant 7: I’ll try and approach the answer to say that it could not 
be seen as an either/or scenario. To just think that you need to use 
medication is ignoring a total critical part of the reality of care. To try 
and focus just on psychosocial issues without the immediate, if I can 
call it the medical side of it, you would also be I think, not dealing with 
the whole picture. So in my view, I think that you should always 
include at least 3 issues together, and that it is not an either/or choice, 
I don’t think it should be. 
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7.2.9.) Schizophrenia Understood as a Biological Illness 
The majority of participants (5 out of 8) made it clear that they understand 
schizophrenia to be a biologically based disease, and that interventions need to reflect 
this fact.  
Participant 1: Ok, uh, psychologically, I don’t think there is a place 
initially. We know that it’s a biological illness, and it’s got clearly 
shown biological undertones. 
Participant 4: Now we, I think we’ve been made aware as 
psychiatrists in terms of the positive effects of medication, structurally 
on the brain and all that. 
Participant 5: I mean schizophrenia is a biological illness, so 
biological treatment is the mainstay, so effectiveness would not 
compare, in terms of not being as good as medication biologically... 
we are very very clear on schizophrenia being a very very severe 
biological illness. 
Participant 8: I think South African research is very much in keeping 
with international trends in terms of etiology and management of 
schizophrenia being largely biologically based with antipsychotics... 
there’s well-documented evidence for biological treatments for an 




7.3.1.) Psychosocial Interventions Not used in the Treatment of Acute-Phase 
Schizophrenic Psychosis 
The majority of participants (7 out of 8) stated that they do not employ psychological 
interventions in acute-phase schizophrenic psychosis.  
Participant 1: In the acute phase I haven’t found it useful. I don’t use 
the psychologists for that no. 
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Participant 8: Well I don’t think it is going to be very helpful when the 
patient is psychotic. You can’t talk to them cause they don’t have any 
sense… But once somebody is psychotic, and they are out of touch 
with reality, once they say they are not from this planet, and they are 
directly from God, like, um, there’s really no alternative to 
medication… I don’t think that psychosocial interventions are an 
alternative to somebody who is psychotic.  
There was one participant who stated that they do in fact employ psychological 
interventions in the acute phase on his ward. These interventions do not, however, 
include insight-based individual psychotherapy.  
Respondent 7: Our psychology colleagues have 3 sessions or groups, 
during the week, a more introductory group on a Monday, a sort of 
progress group on Wednesday, and a discharge, or being prepared for 
discharge group on a Friday so, that doesn’t mean that any 
psychological support process has been concluded by then, but in 
attempt to see how one can manage the further containment or 
experience of being on the ward, being like in a situation of having to 
do with different people, strange fellow patients, staff, medication, 
experience is part of it, so we try to touch base in 3 different phases of 
it, and see that as the process, rather than having an individual process 
with each individual person. That does not say that we are not doing 
individual therapy, it is definitely there too, primarily on a constant 
interview basis, getting collateral, making them part of family therapy, 
is most definitely part of it. 
 
7.3.2.) Medication Primarily Indicated in the Treatment of Schizophrenia 
The majority of participants (7 out of 8) stated that medication is the mainstay in the 
treatment of schizophrenia.  
Participant 2: I am very pro medication in the acute phase. I do not 
think that patients should be made to believe that they can be healed 
by psychotherapy. The mainstay is medication and that should be clear 
 48 
from the start. I don’t think that people should be made to believe that 
you can heal it with talk therapy. 
Participant 5: Well, acute-phase schizophrenia psychosis implies that 
the patient is at that time acutely ill, and our definition of acute 
psychosis is that it is people who warrant urgent biological 
intervention first and foremost.  
 
7.3.3.) Psychiatrists Not Willing to Withhold Medication 
Six out of eight participants stated that they are not willing to withhold medication in 
the treatment of schizophrenia. 
Participant 3: No, because of all the answers that I have given before. 
There’s well documented evidence for biological treatments for an 
illness like schizophrenia. 
Participant 4: If somebody presents to me and they are psychotic for 
whatever reason, and I believe that it is the result of schizophrenia and 
not a medical condition, or a substance or something of that nature, I 
would not withhold medication under any circumstances. 
 
7.3.4.) Psychiatrists Willing to Minimize Medication 
The majority of participants (5 out of 8) indicated that, under the right circumstances, 
they would be willing to decrease the dose of medication. The dosage would not, 
however, be decreased below the effective threshold, and it would not be done in view 
of the implementation of insight-based psychological interventions.  
Participant 1: So ja, um, the medication definitely has an impact on 
patients, but for me it is, if a patient has to live in the community, they 
cannot sit with the impairment that they sit with here, so we have to 
decrease the dose and make it possible for them to live, if they are that 
sedated and impaired they will stop the medication, so hopefully then 
they can start with therapy. But when I use such high dosages of 
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medication they are acutely ill, and are a danger to themselves and 
others, and therapy might not be indicated. Once they are not that 
problematic, I decrease dosage so that they are more likely to stay on 
the medication and more likely to function. 
Participant 4: One would try to get away with the lowest allowable 
dose, so if I think that the patient was doing well with regard to the 
psychosocial treatment that was available to them, obviously I would 
decrease to as little as possible. 
 
7.3.5.) Practices in Terms of Delay of medication 
The majority of participants (5 out of 8) stated that, if a diagnosis of schizophrenia 
has been made, they administer medication as early as possible, and that there are 
severe risks to delaying medication, as the psychotic process is toxic. 
Participant 1: I think the risks are too obvious and too great to not 
help. I mean the whole drive in psychiatry at the moment is to 
diagnose early, and start treatment early, and therefore prevent, um, 
further progression of the illness, and that’s the whole debate at the 
moment, at what point is it enough to start medication, which is a 
drastic step. If psychology has a role in the pre-morbid intervention, 
I’m not sure, I don’t know enough. Actually once they have been 
diagnosed I think they should be treated. 
Participant 5: We also know that the toxicity of ongoing psychosis is 
well documented as well, and that the earlier you intervene and treat, 
the better the long-term outcome may be.  
Participant 6: I think in the acute phase you need to get rid of the 
psychotic symptoms firstly because of the distress it causes the patient 
and secondly because of the toxicity of the psychotic state to the 
individual. 
 50 
Contrastingly, one participant stated that they have delayed medication in the 
treatment of acute-phase schizophrenic psychosis, although it was stated that this is 
not standard practice.  
Participant 3: Yes I have, um, like I said this would be in cases where 
the patient presents with psychosis, possible schizophrenia psychosis, 
but I am not sure if he needs medication, or if this is just a reaction to 
an underlying psychological problem, but this would be cases where 
patients are obviously not a danger to themselves or others, and are 
more contained. But yes I have done that, and sort of, also bearing 
that in mind, you also need a psychologist that is prepared to work 
with a patient like that, so I have been fortunate in that I have a few 
intern psychologists that are keen to try it. Not many, I think less than 
ten patients.  
 
7.3.6.) Treatment Approach Based on Available Resources 
Half of the participants stated that a lack of resources greatly influences their 
treatment approaches with regard to schizophrenia, and that this has an impact on 
their use of alternative interventions, or lack thereof.  
Participant 3: I often wonder if what we are doing is the right way, its 
the only way that we have, the only choice, but if we had the facilities 
or the time for this I would be very interested to see what the effect 
would be. Because like I say there is often doubt in prescribing 
medication, increasing it all the time until the patient gets better, it 
would be good to know that there’s an alternative. But we often deal 
here, you have to get the patient better to get the bed open for the next 
aggressive demanding patient, so the luxury of waiting and seeing is 
sometimes necessary but not possible, and um, so that’s why I say if 
we could work on the circumstances and look at this I would be 
fascinated, if there is an alternative to just medicating. 
Participant 6: I know that right here at X I could not do that with my 
patients, there’s not the skills, there’s not the people available, so on a 
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purely practical level I know I could not do anything like that to allow 
me to not give medication. 
 
7.3.7.) Query of Diagnosis in Cases of Schizophrenia indicated for Psychosocial 
Intervention 
Half of the participants stated that, if a psychological intervention were indicated for 
acute-phase schizophrenic psychosis, they would question the diagnosis of 
schizophrenia.  
Participant 4: And we’ve had some good results with psychological, 
but then I query the diagnosis of schizophrenia, they come with a 
diagnosis of schizophrenia, but I then doubt. Because we mostly get 
referrals and the diagnosis says schizophrenia, but then we take time 
or the psychologist takes time, and we sort of revisit the diagnosis, and 
then I don’t think it’s schizophrenia. 
Participant 8: Cause that may often be still a question, it may be co-
morbidity, it may be substance related, but acute psychotic 
presentations, what one is saying in terms of the medication treatment 
is pertaining specifically to schizophrenia. 
 
7.4.) DISCUSSION 
The aims of this research project were, firstly, to determine the knowledge that 
psychiatrists, currently practicing in acute psychiatric wards in government hospitals 
in Johannesburg South Africa, have of combined minimal medication and 
psychosocial interventions in acute-phase schizophrenic psychosis. A second aim was 
to explore the attitudes that these psychiatrists have toward combined minimal 
medication and psychosocial interventions in acute-phase schizophrenic psychosis. 
Lastly, a third aim was to determine the practices of these psychiatrists when treating 
acute-phase schizophrenic psychosis.    
The results clearly indicate that none of the participants had in-depth knowledge of 
combined minimal medication and psychosocial interventions in acute-phase 
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schizophrenic psychosis. The majority of participants (5 out of 8) were completely 
unaware of these interventions, while of the three participants who were aware of 
them, only one had some knowledge on the subject. With regard to attitudes, the 
majority of participants (5 out of 8) clearly stated that they would be against the use of 
combined minimal medication and psychosocial interventions in acute-phase 
schizophrenic psychosis, as it would be unethical and negligent to withhold or 
minimize medication due to both the distress caused by psychosis, and the toxic effect 
that it has on the brain.  All of the participants specified that they view psychosocial 
interventions (at any phase of psychosis) as supportive only (and not having any 
direct role in managing or reducing symptoms), with some participants stating that 
psychological interventions need to focus on the needs of the family of the patient. 
Most participants (7 out of 8) indicated that the implementation of combined minimal 
medication interventions in acute-phase schizophrenic psychosis would not be viable 
in South Africa, as the required resources are not available. With regard to practices, 
the majority of participants (7 out of 8) stated that they do not use any form of 
psychological intervention aimed at the patient during acute-phase schizophrenic 
psychosis, as the patient cannot make use of a psychological intervention. This view 
was supplemented by the fact that the majority of participants (7 out of 8) stated that 
medication is the mainstay in the treatment of acute-phase schizophrenic psychosis as 
it is a biological disorder. Most of the participants (5 out of 8) would not be willing to 
minimize or withhold medication during an episode of acute-phase schizophrenic 
psychosis, while two participants did not comment on this, and one stated that he has 
withheld medication in cases where there was uncertainty regarding the diagnosis. 
Again the issue of available resources was raised, as half of the participants stated that 
the lack of resources in public mental health care in South Africa has a marked 
influence on the interventions that they choose to implement in the treatment of acute-
phase schizophrenic psychosis. These findings will now be discussed in more detail.  
The knowledge section of the results consists of two sub-themes, the first being 
‘Problems Related to the Definition of Schizophrenia and its Phases’. Although the 
researcher did not originally set out to investigate psychiatrists’ understanding of the 
definition of schizophrenia and its phases, it is crucial to indicate that this theme did 
in fact emerge, as each participant’s understanding of the definition of schizophrenia 
will influence their subsequent use of the term and their understanding of 
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schizophrenia’s progression from one phase to another. It was, however, 
communicated to participants that acute-phase schizophrenic psychosis was defined 
within the study as referring to a patient who has been diagnosed with schizophrenia 
and is acutely psychotic. This theme is also linked to the literature that discusses the 
use and misuse of the term schizophrenia, and how the differing opinions regarding a 
definition alter the way that the disorder is understood, researched, and treated (Boyle, 
1990; Kennard, 2009; Potvin, Stip, & Roy, 2005).   
The second theme focused on the participants’ awareness and knowledge of combined 
minimal medication and psychosocial interventions in acute-phase schizophrenic 
psychosis. The majority of participants (5 out of 8) were unaware of any minimal or 
delayed medication interventions, or psychological interventions, in acute-phase 
schizophrenic psychosis. It is not possible to measure the novelty of this finding 
against a locally relevant understanding or baseline of what psychiatrists in South 
Africa do know, or should know, about alternative interventions in acute-phase 
schizophrenic psychosis, as an exhaustive literature review has produced no such 
studies. This finding was, however, in line with relevant international treatment 
guidelines, as well as local treatment guidelines, as South African psychiatric training 
and treatment approaches in schizophrenia are very much in keeping with American 
and British treatment guidelines, and alternative interventions are not indicated for 
acute-phase schizophrenic psychosis in these guidelines (APA, 2009; Department of 
Health, 2008; NICE, 2002).  
The attitudes section of the results consists of multiple sub-themes, some of which 
have been grouped as they inform one another. Participants were clearly against the 
use of minimal medication or psychosocial interventions that incorporate the elements 
of the Soteria model when treating acute-phase schizophrenic psychosis. These 
elements include the minimal or delayed use of antipsychotic medication, an 
unstructured non-hierarchical approach, the understanding that therapeutic 
relationships are pivotal in treatment, and the use of non-professional staff (Bola & 
Mosher, 2003). These responses are reflective of the rationale provided in the 
literature advocating against the minimizing or withholding of medication when 
treating a patient suffering from acute-phase schizophrenic psychosis. This rationale 
in part revolves around two important issues, the first being that psychosis is toxic to 
the brain, and the second that psychosis is greatly distressing to both the sufferer and 
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to those around them (Potvin, Stip, & Roy, 2005). Both of these issues were cited by 
participants and given as reasons for viewing certain aspects of the proposed minimal 
medication interventions as unethical and negligent. Half of the participants indicated 
that they view psychological interventions to be more indicated in cases of ‘soft’ 
psychosis. Although there are no formal definitions of ‘soft’ and ‘hard’ psychosis, 
participants did distinguish between the two as they indicated that, at times, there are 
certain behavioral problems and aggression coinciding with acute-phase 
schizophrenic psychosis, that necessitates the use of antipsychotic medication in order 
to ensure the safety of the patient and those around them, perhaps partially influencing 
these cases being referred to as ‘hard’ psychosis. Although there are no formal 
distinctions between ‘soft’ and ‘hard’ psychosis, participants did seem to view ‘hard’ 
psychosis as denoting a more acutely psychotic and behaviorally problematic state 
than ‘soft psychosis’. Interestingly, the literature does make a distinction between 
‘organic psychosis’, which clinically presents with hallucinations, delusions, and 
marked disordered thought, and a newly proposed term ‘behavioral psychosis’ which 
is typically characterized by disturbances in reality testing or “minor, nonlocalizable, 
objective abnormalities… that represent a developmental lag rather than a fixed 
abnormality” (Barkus, Stirling, Hopkins, & Lewis, 2006, p.1; Venugopal & Murali, 
2010). The latter definition does not seem to imply acute-phase schizophrenic 
psychosis as informed by the DSM-IV-TR (American Psychiatric Association, DSM-
IV-TR, 2000).  
The view that it is unethical and negligent to withhold or delay medical treatment, that 
psychotic schizophrenic patients cannot make use of psychological interventions, and 
the fact that there are severe behavioral problems that need to be taken into account in 
many of the institutions where the participants practice, all contextualize and motivate 
the fact that the participants unanimously stated that psychosocial interventions in 
acute-phase schizophrenic psychosis are seen as an adjunct to medication in the non-
acute phase only. These responses are in concordance with the treatment guidelines as 
stated by the APA (2009) and the Department of Health of South Africa (2008).  
Participants’ view of psychosocial interventions as supportive only, is further 
informed by their view that schizophrenia is understood as a biological illness. The 
majority of participants (5 out of 8) stated that schizophrenia is caused by biological 
processes, and that treatment should reflect this. This attitude toward the cause and 
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nature of schizophrenia is widely cited in the literature, and typically presented as the 
main rationale for the use of medication in the treatment of acute-phase schizophrenic 
psychosis (Laungani, 2002; Ross, 2006). Biases toward a biological explanation for 
the aetiology of schizophrenia is viewed by some as reductionist, as Bentall (2009) 
points out that “biological investigators have almost universally failed to consider the 
possibility that their findings might reflect the tribulations of life, rather than some 
legion or genetic scar carried by the victim from birth” (p.152).  
Despite the fact that psychosocial interventions are seen as supportive only (as 
opposed to having any use in managing or reducing core symptoms), half of the 
participants stressed the notion that the treatment of schizophrenia necessitates a 
biopsychosocial approach, as there are a multitude of psychosocial environmental 
factors that influence the development of the disorder, relapse rates, and successful 
treatment (Koehler, 2004; Read, Seymour & Mosher, 2004). This advocating of an 
integrated approach does not, however, resonate with Alanen’s (1997) idea of patient-
orientated treatment, as the psychosocial intervention as seen by participants acts as 
an adjunct to support the use of medication as primary intervention, and not as a 
possible primary intervention in its own right. This was further emphasized as 
participants stressed that the psychosocial interventions in acute-phase schizophrenic 
psychosis that are indicated as supportive, do not include insight-based psychological 
interventions such as psychodynamic psychotherapy. Psychodynamic psychotherapy 
is at the forefront of contentious aspects inherent in psychological interventions in 
acute-phase schizophrenic psychosis as it necessitates a patient that can make use of 
interpretations, and insight-orientated therapy. The literature reflects this inasmuch as 
none of the treatment guidelines advocate its use in the acute phase, and most of them 
advise against it, including as an adjunct to medication (APA, 2009; Dixon et al., 
2009; Lehman & Steinwachs, 1998a; Lehman & Steinwachs, 1998b; NICE, 2002). 
Most of the participants (7 out of 8) made it clear that they are against the use of 
psychodynamic interventions in acute-phase schizophrenic psychosis. Participants 
substantiated this view by stating that the acutely psychotic schizophrenic patient is 
too agitated to tolerate increased anxiety, and that psychosis renders them incapable 
of making use of insight-orientated therapy as they are thought disordered and 
incapable of reality testing due to tenuous ego-boundaries. This view, although 
somewhat anticipated based on the literature, and in accord with relevant treatment 
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guidelines, is also partially in opposition to arguments put forward by proponents of 
psychodynamic approaches to the treatment of acute-phase schizophrenic psychosis 
who state that it allows clinicians to make sense of patients’ bizarre and eccentric 
communications via the use of an in-depth theoretical framework (Jackson, 2009; 
Martindale, 2008). These proponents do not, however, explicitly advocate for the use 
of psychodynamic interventions in acute-phase schizophrenic psychosis, but rather 
highlight the fact that a psychodynamic approach enables the clinician to think about 
the dynamics of the patient, and make some sense of the bizarre content of their 
thought and speech (Jackson, 2009; Martindale, 2008).   
Cognitive Behavioral Therapy (CBT) was viewed in a contrasting light, with the 
majority of participants (5 out of 8) stating that they would be for its use, although as 
supportive, and a supplement to medication only in the non-acute phase. The main 
reason provided by participants for this was that CBT is a time-limited, symptom-
focused, and scientifically proven and verifiable psychological intervention, which 
reflects the rationale provided by the most influential treatment guidelines which 
indicate that, unlike Psychodynamic interventions, CBT as supportive intervention 
warrants inclusion in the recommendations precisely because of its scientifically 
proven efficacy (APA, 2009; Fenton, 2000; Kennard, 2009; Lehman & Steinwachs, 
1998a; Lehman & Steinwachs, 1998b; NICE, 2002). Lastly, participants’ attitudes 
toward combined minimal medication and psychosocial interventions in acute-phase 
schizophrenic psychosis were heavily influenced by the under-resourced nature of the 
South African health care system, and the contrasting resource intensive nature of the 
proposed alternative interventions (Koen, Magni, Niehaus, & le Roux, 2008; Trump 
& Hugo, 2006). The majority of participants indicated that, due to a lack of resources, 
they do not think that the proposed alternative interventions would be viable in South 
Africa.  
Psychiatrists’ practices in terms of the treatment of schizophrenia as reported by 
participants clearly reflect the treatment guidelines as stipulated by the American 
Psychiatric Association (2009), the NICE (2002), and the Department of Health 
(2008). In accordance with these guidelines all of the participants stated that they do 
not employ psychotherapeutic interventions when treating acute-phase schizophrenic 
psychosis, with some indicating that it instills false hope to lead a patient to believe 
that schizophrenia can be treated with psychotherapy. One participant indicated that 
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they do employ psychotherapeutic interventions, but that these focus only on gaining 
collateral information, aiding the patient in medication compliant behavior, and 
supporting the patient in terms of their adjustment to the ward and readiness to be 
reintroduced into society.  
In terms of psychosocial interventions, only two forms were mentioned by half of the 
participants, and it was stated that these were used as an adjunct, aimed at supporting 
the medication-orientated intervention. These were, firstly, interventions aimed at 
educating and supporting the patient’s family, and secondly, interventions aimed at 
supporting the patient in the process of being reintroduced into the community, which 
included skills training and Assertive Community Training. Half of the participants 
stated that they would seriously query a diagnosis of schizophrenia if a psychological 
intervention were in fact indicated as treatment in any given case. Psychological 
interventions are viewed as supportive only as indicated in the ‘attitudes’ section, 
which is further confirmed by the fact that most of the participants (7 out of 8) made it 
clear that they always use medication to treat acute-phase schizophrenic psychosis, as 
this is the mainstay. This practice is also indicative of a strict adherence to the 
aforementioned treatment guidelines (APA, 2009; Department of Health, 2008; NICE, 
2002). The majority of participants (5 out of 8) stated that they do not minimize, 
delay, or withhold medication when treating acute-phase schizophrenic psychosis, as 
their practice is informed by their understanding that schizophrenia is a biological 
disorder, that psychotherapeutic interventions are not indicated for its treatment, and 
that it is negligent and unethical to minimize, delay, or withhold medication in a 
patient who is diagnosed as schizophrenic. It was indicated that the current thinking in 
psychiatry is moving towards treating as early as possible to prevent the progression 
of the disorder, and that, rather than delaying medication, participants would treat as 
soon as a diagnosis of schizophrenia has been made. This perspective is also in 
keeping with the current thinking influencing the development of the DSM-V, as 
Attenuated Psychotic Symptoms Syndrome is currently being proposed for inclusion 
in the manual in order to aid the early detection and treatment of schizophrenia (APA, 
2010). Participants did, however, state that they treat with the minimal effective 
dosage, as they want to avoid the severe side effects of medication as far as possible. 
Significantly, one participant stated that they have delayed medication in cases where 
they were considering a diagnosis of schizophrenic psychosis, but were not certain as 
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the possibility that the psychosis may be the result of an underlying psychological 
problem was being considered. This participant stated that this was not standard 
practice, and that it has been the case with roughly ten patients. This is, however, in 
marked contrast to the practices as stated by the other participants, and, in some 
respects in opposition to the indicated treatment guidelines for schizophrenia, 
although this approach could be defended in light of the diagnosis being questioned, 
which further indicates the complex nature of psychiatric care (APA, 2009; 
Department of Health).  
The literature abounds with similar alternative treatment approaches that focus on a 
delay of medication and a more emphasized role for psychotherapeutic interventions 
in the treatment of schizophrenia in the acute phase (Aderhold, 2009; Aderhold & 
Gottwalz, 2004; Bola, 2006; Bola et al., 2009; Bola & Mosher, 2003; Calton et al. 
2007; Chen & Moreno, 2006; Dudley & Turkington, 2009; Irwin, 2004; Kanas, 2000; 
Kennard, 2009; Koehler & Silver, 2009; Morrison, 2004; Mosher, 2004; Mosher & 
Bola, 2004; Rogers, Gendlin, Kiesler, & Traux, 1967; Scott & Dixon, 1995; Silver, 
2000; Silver et al., 2004; Thorgaard & Rosenbaum, 2006), and there are a myriad of 
factors that could influence a psychiatrist’s decision to withhold or delay treatment in 
favor of more suitable alternatives. These factors include available resources in terms 
of beds, staff and training; possible behavioral problems and aggression in patients; 
patients’ response to antipsychotic medication; and indications of psychological 
causes for psychosis such as severe stress or trauma (Jansen et al., 2004; Koehler, 
2004; Lewis, 2008; Ross, 2006). The problems inherent in such an alternative 
approach to the treatment of acute-phase schizophrenic psychosis include: firstly, the 
fact that these alternatives are not proven effective (Lehman & Steinwachs, 1998a); 
secondly, the aggressive nature of many of the institutionalized patients who suffer 
from acute-phase schizophrenic psychosis, this being in direct opposition to the 
contained patient that is described by the aforementioned participant; and thirdly, the 
serious lack of resources necessary to implement these alternative treatment 
approaches. One participant stated that the delay of medication in favor of a 
psychological intervention is practical only if, among other factors, there are 
psychologists available, able, and willing to do therapy with psychotic patients, which 
is rarely the case. The effect that South Africa’s resource strained health care system 
has on psychiatrists’ treatment approaches is evident. Half of the participants stated 
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that a lack of resources greatly influences their treatment approaches with regard to 
schizophrenia, and that this does have an impact on their use of alternative 
interventions, or lack thereof.  
 
7.5.) CONCLUSION 
While it is clear that the majority of participants had no in-depth knowledge of 
combined minimal medication and psychosocial interventions in acute-phase 
schizophrenic psychosis, it is also clear that the participants were not in favor of these 
alternative approaches when presented with the rationales and guidelines. It was also 
shown that participants did not view their lack of knowledge as a factor that hinders 
their treatment approaches, as they are following scientifically verified treatment 
guidelines. The proposed alternative interventions were viewed as contraindicated for 
the treatment of schizophrenia and/or psychosis, while psychological interventions 
were seen as supportive only, and not to be used in the acute psychotic phase of 
schizophrenia. These factors, and the predominantly shared perspective that 
alternative interventions in acute-phase schizophrenic psychosis are unethical and 
negligent, combined with the severely under-resourced nature of the South African 
health care system, all highlight the marked difficulties involved in the proposed 
alternative interventions being implemented in psychiatric health care in South Africa. 
The resource intensive nature of the treatment of schizophrenia, and patients’ 
difficulties regarding medication compliance and side effects, do, however, remain 
problems that need to be addressed in innovative, sustainable, and viable ways. 
Although medication remains the mainstay in the treatment of acute-phase 
schizophrenic psychosis in South Africa, there do seem to be certain psychosocial and 
psychological elements inherent in alternative treatment that need to be investigated 
in order to address the current problems involved in treatment with antipsychotics. 
Psychiatric care in South Africa could benefit from actively and continually engaging 
with other mental health care professionals around these complicated issues, in order 
to start finding feasible and locally relevant alternatives that supplement current 
treatment approaches. Further research projects in terms of what the majority of 
psychiatrists in South Africa view as essential in the treatment of schizophrenia, and 
how these treatment approaches are informed, are also recommended. A summarized 
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list of recommendations follow, all of which are aimed at improving current practices 




• Research on a larger scale, aimed at exploring the treatment approaches of 
psychiatrists in South Africa with regard to schizophrenic psychosis. 
• Workshops or focus groups, aimed at allowing different mental health 
professionals including psychiatrists, psychologists, occupational therapists, 
and nurses to discuss and address current problems involved in the treatment 
of schizophrenic psychosis, and review the possibilities and opportunities to 
implement further psychosocial and psychological interventions in treatment. 
• A review of the application of current available resources, as well as 
alternatives that include approaches that regulate the therapeutic and 
containing elements involved in the contact between psychotic patients and 
those involved in their care and treatment. 
• The establishment of locally relevant treatment guidelines for schizophrenia.  
 
7.7.) LIMITATIONS OF THE STUDY 
Due to the specific scope of the study, and the large volume and depth of the data, the 
researcher was forced to omit certain themes and aspects of the participants’ 
knowledge, attitudes, and practices with regard to alternative interventions and the 
treatment of schizophrenia, although no themes that address the research questions 
were left out. The data that has been included represents the responses that address the 
specific aims of the research. The researcher’s relative lack of exposure to 
schizophrenic patients in an acutely psychotic state could possibly have lead to the 
study being predominantly theory-driven, leading to inadequate consideration of the 
practical implications of working with this specific group of patients.  
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In interpretive research there is an acknowledgement that the researcher, the 
participants, and the research field are all implicated in an evolving and dynamic 
process in which all of these elements mutually affect one another (Oliver, 2004). 
Implicitly, the researcher represents a body of professionals which may typically be 
seen as being opposed to the primary use of medication in the treatment of 
schizophrenia. This could have led to participants experiencing the interview as anti-
psychiatric, or a witch-hunt of sorts, despite the fact that the researcher was aware of 
the possibility, and tried to control for it by remaining relatively neutral in approach.  
The final question on the interview schedule (How does the response of a patient in 
acute-phase schizophrenic psychosis to psychosocial interventions in the hospital 
setting influence the dosage of medication that you prescribe?) was possibly leading, 
as it implies that the patient’s response to a psychosocial intervention should in fact 
influence dosage.  
As it has been mentioned, the researcher lacks experience in working with the 
identified patient group, and thus relies predominantly on theoretical knowledge on 
the subject. This knowledge is largely informed by the training received, which is 
rooted in a psychodynamic school of thought. This could have influenced the way in 
which participants answered the questions, and the extent to which they were willing 
to engage around psychological interventions, in particular psychodynamically driven 
interventions, although their engagement was critical (Eliot, Fischer, & Rennie, 
1999).  
The way in which the sample group was obtained could have lead to possible 
sampling bias, as participants were obtained through a network known to the 
researcher and the supervisor. The group of participants was, however, chosen to 
represent the larger public hospitals in Johannesburg, South Africa, although more 
information cannot be given in this regard as the researcher has an ethical 
responsibility to protect the identity of the research participants. Due to the nature of a 
qualitative study, and the consequent small sample size, the findings cannot be 
generalized to a larger population. A questionnaire method may be a way of accessing 
a broader population, although the researcher’s decision against this is discussed in 
the ‘Methods’ section. In an effort to critically engage the participants in a discussion 
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of alternative intervention models, the researcher’s presentation of the Soteria model 
could have invited critique, which may have distorted participants’ attitudes toward it.  
Lastly, as is the nature of qualitative research, this study defines the reality that it 
claims to measure. Thus assumed shared understandings of certain definitions may 
skew what is understood when a question is asked, and when an answer is provided. 
This was also addressed in the ‘Results’ section, as one of the themes dealt with the 
different understandings of definitions relating to schizophrenia and its respective 
phases. The research supervisor, as well as a research psychology doctorate student 
from the University of Pretoria did, however, act as checks in this regard to help 



















Aaltonen, J., Alanen, Y., Cullberg, J., Haugsgjerd, S., Levander, S., & Rosenbaum, B. 
(2009). Northern Europe: Developments in the Scandinavian Countries. In 
Olanen, Y., Chávez, G., Silver, A., & Martindale, B. (2009). 
Psychotherapeutic Approaches to Schizophrenic Psychoses: Past, Present and 
Future. London: Routledge. 
Adrerhold, V. (2009). Soteria: A Treatment Model and a Reform Movement in 
Psychiatry. In Olanen, Y., Chávez, G., Silver, A., & Martindale, B. (2009). 
Psychotherapeutic Approaches to Schizophrenic Psychoses: Past, Present and 
Future. London: Routledge. 
Aderhold, V., & Gottwalz, E. (2004). Family Therapy and Schizophrenia: Replacing 
Ideology with Openness. In – Read, J., Mosher, L., & Bentall, R. (2004). 
Models of Madness: Psychological, Social and Biological Approaches to 
Schizophrenia. UK: Brunner-Routledge.  
Alanen. Y. (1997). Schizophrenia: Its Origins and Need-Adapted Treatment. In 
Johannessen, O., Martindale, B., & Cullberg, J. (2006). Evolving Psychosis: 
Different Stages, Different Treatments. London: Routledge.  
Alanen, Y., Chávez, M., Silver, A., & Martindale, B. (2009). Further Development of 
Treatment Approaches to Schizophrenic Psychoses: An Integrated View. In 
Olanen, Y., Chávez, G., Silver, A., & Martindale, B. (2009). 
Psychotherapeutic Approaches to Schizophrenic Psychoses: Past, Present and 
Future. London: Routledge. 
American Psychiatric Association (2000). Diagnostic and Statistical Manual of 
Mental Disorders (4th ed. text revision). Arlington: American Psychiatric 
Association.  
American Psychiatric Association (2009). Practice Guidelines for the Treatment of 
Patients with Schizophrenia: Second edition. Retrieved January 5, 2010, from 
http://www.psychiatryonline.com/pracGuide/pracGuideTopic_6.aspx 
 64 
American Psychiatric Association (2010). DSM V Development: Attenuated Psychotic 
Symptoms Syndrome. Retrieved September 15, from, 
http://www.dsm5.org/ProposedRevisions/Pages/proposedrevision.aspx?rid=41
2 
Andreasen, N. (1991). Assessment Issues and the Cost of Schizophrenia. Retrieved 
January, 13, 2010, from 
http://schizophreniabulletin.oxfordjournals.org/cgi/reprint/17/3/475 
Arvantis, L., & Miller, B. (1997). Multiple Fixed Doses of ‘Serequel’ (Quetiapine) in 
Patients with Acute Exacerbation of Schizophrenia: A Comparison with 






Andrews, G., Sanderson, K., Corry, J., Issakidis, C.,  & Lapsley, H. (2003). Cost-
Effectiveness of Current and Optimal Treatment of Schizophrenia. Retrieved 
January 15, 2010, from http://bjp.rcpsych.org/cgi/reprint/183/5/427 
Barkus, F., Stirling, J., Hopkins, R., & Lewis, S. (2006). The Presence of 
Neurological Soft Signs Along the Psychosis Process Continuim. Retrieved 
September 3, 2010, from  
http://schizophreniabulletin.oxfordjournals.org/content/early/2006/01/11/schb
ul.sbj037.full.pdf 
Belleza, T., Hall, K., Hopkins, K., Rappaport, M., & Silverman, J. (1978). Are There 
Schizophrenics for Whom Drugs May be Unnecessary or Contraindicated? 
International Pharmacopsychiatry, Volume 13(2), 100-111. 




Bentall, R. (2006). Madness Explained: Why We Must Reject the Kraepelinian 
Paradigm and Replace it with a ‘Comlpaint-Orientated’ Approach to 






Bola, J. (2006). Medication-Free Research in Early Episode Psychosis: Evidence of 
Long-Term Harm? Retrieved December 23, 2009, from 
http://schizophreniabulletin.oxfordjournals.org/cgi/reprint/32/2/288 
Bola, J., Lehtinen, K., Cullberg, J., & Ciompi, L. (2009). Psychosocial Treatment, 
Antipsychotic Postponement, and Low-Dose Medication Strategies in First-
Episode Psychosis: A Review of the Literature. In Psychosis: Psychological 
Social and Integrative Approaches. Oxon, UK: Routledge  
 Bola, J., & Mosher, L. (2003). Treatment of Acute Psychosis Without Neuroleptics: 
Two-Year Outcomes From the Soteria Project. Retrieved November 18, 2009, 
from http://www.moshersoteria.com/bola.pdf 
Boisen, A. (1942). The Form and Content of Schizophrenic Thinking. In Belleza, T., 
Hall, K., Hopkins, K., Rappaport, M., & Silverman, J. (1978). Are There 
Schizophrenics for Whom Drugs May be Unnecessary or Contraindicated? 
International Pharmacopsychiatry, Volume 13(2), 100-111. 
Boyatzis, R. (1998). Transforming Qualitative Information. Thematic Analysis and 
Code Development. California: Sage Publications. 
Boyle, M. (1990). Schizophrenia: A Scientific Delusion? London: Routledge.  
Buckley, P., Miller, A., Chiles, J., & Sajatovic, M. (1999). Implementing Effectiveness 
Research and Improving Care fro Schizophrenia in Real-World Settings. 
Retrieved November 20, 2009, from 
http://www.ajmc.com/media/pdf/AJMC99SpcjunBuckleySP47_56.pdf 
 66 
Burns, J. (2008). Dispelling a Myth: Developing World Poverty, Inequality, Violence 
and Social Fragmentation are Not Good for Outcome in Schizophrenia. 




 Calton, T., Ferriter, M., Huband, N., & Spandler, H. (2007). A Systematic Review of 
the Soteria Paradigm for the Treatment of People Diagnosed With 
Schizophrenia. Retrieved November 17, 2009, from 
http://schizophreniabulletin.oxfordjournals.org/cgi/reprint/sbm047v1 
Chen, D., & Moreno, J. (2006). Ethics of Medication-Free Research in Schizophrenia. 
Retrieved December 23, 2009, from 
http://schizophreniabulletin.oxfordjournals.org/cgi/reprint/32/2/307 
Coar, L., & Sim, J. (2006). Interviewing One’s Peers: Methodological Issues in a 
Study of Health Professionals. Retrieved November 26, 2009, from 
http://informahealthcare.com/doi/pdf/10.1080/02813430601008479 
Coffey, A., & Atkinson, P. (1996). Making Sense of Qualitative Data. California: 
Sage Publications.  
Crouch, M. (2006). The Logic of Small Samples in Interview-Based Qualitative 
Research. Retrieved February 4, 2010, from 
http://ssi.sagepub.com/cgi/reprint/45/4/483 
Davis, J., & Leucht, S. (2008). Has Research Informed Us on the Practical Drug 
Treatment of Schizophrenia? Retrieved December 8, 2009, from 
http://schizophreniabulletin.oxfordjournals.org/cgi/reprint/34/3/403 
Department of Health (2008). Standard Treatment Guidelines and Essential Drug 
List for South Africa. Retrieved January 21, 2010, from 
http://www.doh.gov.za/docs/facts-f.html 
Dixon, L., Dickerson, F., Bellack, A., Bennet, M., Dickenson, D., Goldberg, R., et al. 
(2009). The Schizophrenia Patient Outcomes Research Team (PORT): 





Dixon, L., Perkins, D., & Calmes, C. (2009). Guideline Watch (September 2009): 
Practice Guideline for the Treatment of Patients with Schizophrenia. 
Retrieved December 8, 2009, from 
http://www.psychiatryonline.com/content.aspx?aid=501001  
Dudley, R., Brabban, A., & Turkington, D. (2009). Cognitive Behavioural Therapy 
for Psychosis. In Olanen, Y., Chávez, G., Silver, A., & Martindale, B. (2009). 
Psychotherapeutic Approaches to Schizophrenic Psychoses: Past, Present and 
Future. London: Routledge. 
Elliot, R., Fischer, C., & Rennie, D. (1999). Evolving Guidelines for Publication of 
Qualitative Research Studies in Psychology and Related Fields. British 
Journal of Clinical Psychology, Volume38, 215-229.  
Emanuel, E., & Miller, F. (2001). The Ethics of Placebo Controlled Trials – A Middle 
Ground. Retrieved December 23, 2009, from http://0-
ovidsp.tx.ovid.com.innopac.wits.ac.za/sp2.3/ovidweb.cgi?QS2=434f4e1a7 
Emsley, R., & Booysen, F. (2004). Cost-Effectiveness of an Atypical Conventional 
Antipsychotic in South Africa: An Economic Evaluation of Quetiapine Versus 
Haloperidol in the Treatment of Patients Partially Responsive to Previous 
Antipsychotics. Retrieved December 23, 2009, from 
http://sajp.org.za/index.php/sajp/article/view/148/139 
 Emsley, R., Oosthuizen, P., Joubert, A., Hawkridge, S., & Stein, D. (1999). 




Fenton, W. (2000). Evolving Perspectives on Individual Psychotherapy for 
Schizophrenia. Retrieved January 8, 2010, from 
http://schizophreniabulletin.oxfordjournals.org/content/26/1/47.full.pdf 
 68 
Fenton, W., Blyler, C., & Heinssen R. (1997). Determinants of Medication 
Compliance in Schizophrenia: Empirical and Clinical Findings. Retrieved 
January 4, 2010, from 
http://schizophreniabulletin.oxfordjournals.org/cgi/reprint/23/4/637.pdf 
Fink, A., & Kosecoff, J. (1998). How To Conduct Surveys: A Step-By-Step Guide (2nd 
ed.). California: Sage Publications. 
Fosey, E., Harvey, C., McDermott, F., & Davidson, L. (2002). Understanding and 
Evaluating Qualitative Research. Retrieved December 11, 2009, from 
http://informahealthcare.com/doi/pdf/10.1046/j.1440-1614.2002.01100.x 
Geekie, J., & Read, J. (2008). Fragmentation, Invalidation and Spirituality: Personal 
Experiences if Psychosis – Ethical, Research and Clinical Implications. In 
Gleeson, J., Krstev, H., & Killacky, E. (2008). Psychotherapies for the 
Psychoses. London: Routledge.    
Gleeson, J., Krstev, H., & Killacky, E. (2008). Integration and the Psychotherapies for 
Schizophrenia and Psychosis: Where Has the ‘New View’ of Schizophrenia 
Taken Us? In Gleeson, J., Krstev, H., & Killacky, E. (2008). Psychotherapies 
for the Psychoses. London: Routledge. 
Godot, D. (2006). The Medical Model of Psychology: Problems and Solutions. 
Retrieved December 16, 2009, from http://davidgodot.com/pdf/medical-
model.pdf 
Goldner, E., Hsu, L., Waraich, P., & Somers, J. (2002). Prevalence and Incidence 
Studies of Schizophrenic Disorders: A Systematic Review of the Literature. 
Retrieved January 15, 2010, from http://server03.cpa-
apc.org:8080/Publications/Archives/CJP/2002/November/goldner.pdf 
Gottesman, I. & Shields, J. (1976). A Critical Review of Recent Adoption, Twin, and 
Family Studies of Schizophrenia: Behavioral Genetics Perspectives. Retrieved 
December 18, 2009, from 
http://schizophreniabulletin.oxfordjournals.org/cgi/reprint/2/3/360 
Hellewel, J. (1999). Treatment-Resistant Schizophrenia: Reviewing the Options and 
Identifying the Way Forward. Journal of Clinical Psychiatry, 60(23), 14.  
 69 
Hietala, J. (2009). Psychopharmacological Treatment and Psychotherapy in 
Schizophrenic Psychoses. In Olanen, Y., Chávez, G., Silver, A., & Martindale, 
B. (2009). Psychotherapeutic Approaches to Schizophrenic Psychoses: Past, 
Present and Future. London: Routledge. 
Higgs, J., & Titchen, A. (1995). Propositional, Professional, and Personal 
Knowledge in Clinical Reasoning. Oxford: Butterworth-Heinemann. 
Hinshelwood, R. (2002). Symptoms or Relationships. Retrieved December18, 2009, 
from http://www.jstor.org/stable/25227351?seq=2 
Hoffmann, K. (2009). The Burghölzli School: Bleuler, Jung, Spielrein, Binswanger 
and Others. In Olanen, Y., Chávez, G., Silver, A., & Martindale, B. (2009). 
Psychotherapeutic Approaches to Schizophrenic Psychoses: Past, Present and 
Future. London: Routledge. 
Hogarty, G., Kornblith, S., Greenwald, D., DiBarry, I., Cooley, S., Ulrich, R., et al. 
(1997). Three Year Trials of Personal Therapy Among Patients Living With or 
Independent of Family. 1: Description of Study and Effects on Relapse Rates. 
In Johannessen, O., Martindale, B., & Cullberg, J. (2006). Evolving Psychosis: 
Different Stages, Different Treatments. London: Routledge.  
Hopper, K. (2004). Interrogating the Meaning of ‘Culture’ in the WHO International 
Studies of Schizophrenia. In Jenkins, J., & Barret, R. (2004). Schizophrenia, 
Culture, and Subjectivity: The Edge of Experience. New York: Cambridge 
University Press. 
Howell, D. C. (1997). Statistical Methods for Psychology. (4th ed.). Boston: Duxbury 
Press. 
Hughes, D. (1999). Acute Psychopharmacological Management of the Aggressive 
Psychotic Patient. Retrieved January 18, 2010, from 
http://psychservices.psychiatryonline.org/cgi/reprint/50/9/1135 
Irwin, M. (2004). Reversal of Schizophrenia Without Neuroleptics: Ethical Human 
Sciences and Services, 6(1), 53-68. 
 70 
Jablensky, A. (2000). Epidemiology of Schizophrenia: The Global Burden of Disease 
and Dissability. Retrieved January 15, 2010, from 
http://www.springerlink.com/content/7ddjfxtmakg71nc8/fulltext.pdf 
Jackson, M. (2009). Great Britain Part 1: The Contribution of Kleinian Innovations to 
the Treatment of Psychotic Patients. In Olanen, Y., Chávez, G., Silver, A., & 
Martindale, B. (2009). Psychotherapeutic Approaches to Schizophrenic 
Psychoses: Past, Present and Future. London: Routledge. 
Janssen, I., Krabbendam, L., Bak, M., Hanssen, M., Vollebergh, W., & de Graaf., R., 
et al. (2004). Childhood Abuse as a Risk Factor for Psychotic Experiences. 
Retrieved January, 20, 2010, from 
http://www.survivorscotland.org.uk/downloads/files/Krabbendam%20psychos
is%20psy.pdf 
Kanas, N. (2000). Group Therapy and Schizophrenia: An Integrative Model. In 
Martindale, B., Bateman, A., Crowe, M., & Margison, F. (2000). Psychosis: 
Psychological Approaches and their Effectiveness. London: The Royal 
College of Psychiatrists. 
Karon, B. (2003). The Tragedy of Schizophrenia Without Psychotherapy. Journal of 
the American Academy of Psychoanalysis and Dynamic Psychiatry, 31, 89-
118. 
Kasper, S., & Muller-Spahn, F. (2000). Review of Quetiapine and its Clinical 
Applications in Schizophrenia. Retrieved December 19, 2009, from 
http://informahealthcare.com/doi/pdf/10.1517/14656566.1.4.783?cookieSet=
1 
Kendler, K. (1993). The Genetics of Schizophrenia: A Current Genetic-
Epidemiologic Perspective. Retrieved December 18, 2009, from 
http://schizophreniabulletin.oxfordjournals.org/cgi/reprint/19/2/261 
Kennard, D. (2009). Part Two: Psychological Therapies for Schizophrenic Psychoses 
in the UK. In Olanen, Y., Chávez, G., Silver, A., & Martindale, B. (2009). 
Psychotherapeutic Approaches to Schizophrenic Psychoses: Past, Present and 
Future. London: Routledge. 
 71 
Kennard, D. (2009). Opinion Piece: Is It Time for ISPS to Remove the Term 
“Schizophrenia” from its Name? In Psychosis: Psychological Social and 
Integrative Approaches. Oxon, UK: Routledge 
Koehler, B. (2004). Sociocultural Factors in the Development of Schizophrenia. 
Retrieved December 18, 2009, from http://www.isps-
us.org/koehler/sociocultural.htm 
Koehler, B., & Silver, A. (2009). Psychodynamic Treatment of Psychosis in the USA: 
Promoting Development Beyond Biological Reductionism. In Olanen, Y., 
Chávez, G., Silver, A., & Martindale, B. (2009). Psychotherapeutic 
Approaches to Schizophrenic Psychoses: Past, Present and Future. London: 
Routledge. 
Koen, L., Magni, P., Niehaus, D., & le Roux, A. (2008). Antipsychotic Prescription 
Patterns in Xhosa Patients with Schizophrenia or Schizoaffective disorder. 
Retrieved January 18, 2010, from 
http://www.ajop.co.za/Journals/November2008/2008_9.pdf 
Kreyenbuhl, J., Buchanan, R., Dickerson, F., & Dixon, L. (2009). The Schizophrenia 
Patient Outcomes Research Team (PORT): Updated Treatment 
Recommendations 2009. Retrieved January 4, 2010, from 
http://schizophreniabulletin.oxfordjournals.org/cgi/content/fulltextt/sbp130  
Kozumplik, O., & Uzun, S. (2009). Recommendations from Treatment Guidelines for 
Schizophrenia Regarding Monitoring of Side Effects of Antipsychotics: Brief 
Review. Retrieved January 19, 2010, from http://hrcak.srce.hr/file/52211 
Larsen, K. (2008). Biological and Psychological Treatments for Psychosis: An 
Overdue Alliance? In Gleeson, J., Krstev, H., & Killacky, E. (2008). 
Psychotherapies for the Psychoses. London: Routledge.    
Laungani, P. (2002). Mindless Psychiatry and Dubious Ethics. Retrieved December 




Lehman, A., & Steinwachs, D. (1998a). At Issue: Translating Research Into Practice: 
The Schizophrenia Patient Outcomes Research Team (PORT) Treatment 
Recommendations. Retrieved December 17, 2009, from 
http://schizophreniabulletin.oxfordjournals.org/cgi/reprint/24/1/1 
Lehman, A., & Steinwachs, D. (1998b). Patterns of Usual Care for Schizophrenia: 
Initial Results From the Schizophrenia Patients Outcomes Research Team 
(PORT) Client Survey. Retrieved December 17, from 
http://schizophreniabulletin.oxfordjournals.org/cgi/reprint/24/1/11 
Martindale, B. (2008). The Rehabilitation of Psychoanalysis and the Family in 
Psychosis: Recovering from Blaming. In Gleeson, J., Krstev, H., & Killacky, 
E. (2008). Psychotherapies for the Psychoses. London: Routledge.    
McBurney, D. (2000). Research Methods (5th ed.). University of Pittsburgh: Thomson 
Wadsworth. 
McEvoy, J. (2007). The Cost of Schizophrenia. Retrieved January 15, 2010, from 
http://article.psychiatrist.com/?ContentType=START&ID=10003365 
Miller, R., McCormack, J., & Sevy, S. (2008). An Integrated Treatment Program for 
First-Episode Schizophrenia. In Gleeson, J., Krstev, H., & Killacky, E. (2008). 
Psychotherapies for the Psychoses. London: Routledge.    
Morrison, A. (2004). Cognitive Therapy for People With Psychosis. In Read, J., 
Mosher, L., & Bentall, R. (2004). Models of Madness: Psychological, Social 
and Biological Approaches to Schizophrenia. UK: Brunner-Routledge. 
Mosher, L. (2004). Non-Hospital, Non-Drug, Intervention with First Episode 
Psychosis. In Read, J., Mosher, L., & Bentall, R. (2004). Models of Madness: 
Psychological, Social and Biological Approaches to Schizophrenia. UK: 
Brunner-Routledge. 
Mosher, L., & Bola, J. (2004). Soteria California and its America Successors: 
Therapeutic Ingredients. Ethical Human Sciences and Services, 6(1) 7-23. 
 73 
Mosher, L., & Vallone, B. (1992). Soteria Project Final Progress Report. Retrieved 
March, 5, 2010, from 
http://psychrights.org/Research/Digest/Effective/SoteriaFinalReport.pdf 
National Institute for Health and Clinical Excellence (2002). Schizophrenia: Care 
Interventions in the Treatment and Management of Schizophrenia in Primary 
and Secondary Care. Retrieved January 8, 2010, from 
http://www.nice.org.uk/nicemedia/pdf/CG82NICEGuideline.pdf 
Nemade, R., & Dombeck, M. (2009). Evidence that Schizophrenia is a Brain Disease. 
Retrieved January 18, 2010, from 
http://www.mentalhelp.net/poc/view_doc.php?type=doc&id=8812&cn=7 
Olanen, Y. (2009). Can We Approach Patients With Schizophrenic Psychosis from a 
Psychological Basis? In Olanen, Y., Chávez, G., Silver, A., & Martindale, B. 
(2009). Psychotherapeutic Approaches to Schizophrenic Psychoses: Past, 
Present and Future. London: Routledge.  
Oliver, P. (2004). Writing Your Thesis. London: Sage. 
Paunovic, V. (2004). New Therapeutic Trends in Psychiatry. Retrieved January 18, 
2010, from http://www.pula-
cong.com/CMS/0156/Rep/Documents04/MT/Paunovic.pdf 
Potter, J., & Wetherell, M. (1987). Discourse and Social Psychology: Beyond 
Attitudes and Behavior. London: Sage.  
Potvin, S., Stip, E., & Roy, J. (2005). Toxic Psychoses as Pharmacological Models of 
Schizophrenia. Retrieved January 18, 2010, from 
http://www.bentham.org/cpsr/sample/cpsr1-1/cpsr1-1/D0003SR.pdf 
Read, J., Perry, B., Moskowitz, A., & Connolly, J. (2001). The Contribution of Early 
Traumatic Events to Schizophrenia in Some Patients:A Traumatic 
Neurodevelopmental Model. Retrieved January 20, 2010, from  
http://www.brown.uk.com/schizophrenia/trauma.pdf 
Read, J., & Hammersley, P. (2006). Can Very Bad Childhoods Drive Us Crazy?: 
Science, Ideology, and Taboo. In Johannessen, J., Martindale, B., & Cullberg, 
 74 
J. (2006). Evolving Psychosis: Different Stages, Different Treatments. UK: 
Routledge. 
Read, J., & Masson, J. (2004). Genetics, Eugenics and Mass Murder. In Read, J., 
Mosher, L., & Bentall, R. (2004). Models of Madness: Psychological, Social 
and Biological Approaches to Schizophrenia. UK: Brunner-Routledge. 
Read, J., Seymour, F., & Mosher, L. (2004). Unhappy Families. In Read, J., Mosher, 
L., & Bentall, R. (2004). Models of Madness: Psychological, Social and 
Biological Approaches to Schizophrenia. UK: Brunner-Routledge. 
Reja, U., Manfreda, K., Hlebec, V., & Vehobar, V. (2003). Open-Ended vs. Close-
Ended Questions in Web Questionnaires. Retrieved December 3, 2009, from 
http://mrvar.fdv.uni-lj.si/pub/mz/mz19/reja.pdf 
Rogers, C., Gendlin, E., Kiesler, D., & Traux, C. (1967). The Therapeutic 
Relationship and its Impact: A Study of Psychotherapy with Schizophrenics. 
Oxford, England: Wisconsin Press.  
Ross, C. (2006). Dissociation and Psychosis: The Need for Integration of Theory and 
Practice. In Johannessen, J., Martindale, B., & Cullberg, J. (2006). Evolving 
Psychosis: Different Stages, Different Treatments. London: Routledge.  
Rössler, W., Salize, H., Os, J., & Riecher- Rössler, A. (2005). Size of Burden of 
Schizophrenia and Psychotic Disorders. Retrieved January 15, 2010, from 
http://www.psychologie.tu-dresden.de/i2/klinische/studium/ss07/roessler-
schizophrenia-europe-2005.pdf 
 Saha, S., Chant, D., Welham, J., & McGrath, J. (2005). A Systematic Review of the 
Prevalence of Schizophrenia. Retrieved January 15, 2010, from 
http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.0020141 
Sarantakos, S. (1998). Social Research. (2nd ed.). In Alston, M., & Bowles, W. (2003). 
Research for Social Workers: An Introduction to Methods. London: 
Routledge. 
 75 
Schwandt, T. (1994). Constructivist, Interpretivist Approaches to Human Inquiry. In 
Denzin, N., & Lincoln, Y. (1994). Handbook of Qualitative Research. 
California: Sage Publications.   
Scott, J., & Dixon, L. (1995). Psychological Interventions for Schizophrenia. 
Retrieved on January 5, 2010, from 
http://schizophreniabulletin.oxfordjournals.org/cgi/reprint/21/4/621 
 Sernyak, M., Lelsie, D., Alarcon, R., Losonczy, M., & Rosenheck, R. (2002). 
Association of Diabetes Mellitus With Use of Atypical Neuroleptics in the 
Treatment of Schizophrenia. Retrieved January 5, 2010, from 
http://ajp.psychiatryonline.org/cgi/reprint/159/4/561 
Silver, A. (2000). Psychoanalysis and Psychosis: Trends and Developments. 
Retrieved December 17, 2009, from 
http://www.springerlink.com/content/v6u8888pnp286562/fulltext.pdf 
Silver, A., Koehler, B., & Karon, B. (2004). Psychodynamic Psychotherapy of 
Schizophrenia. In - Read, J., Mosher, L., & Bentall, R. (2004). Models of 
Madness: Psychological, Social and Biological Approaches to Schizophrenia. 
Hove, UK: Brunner-Routledge. 
Tatarelli, R., Pompili, M., & Girardi, P. (2007). Suicide in Schizophrenia. New York: 
Nova Science Publishers Inc. 
Thorgaard, L., & Rosenbaum, B. (2006). Schizophrenia: Pathogenesis and 
Psychotherapy. In Johannessen, O., Martindale, B., & Cullberg, J. (2006). 
Evolving Psychosis: Different Stages, Different Treatments. London: 
Routledge.  
Tienari, P., Wynne, L., Sorri, A., Lahti, I., Laksy, K., Moring, J., et al. (2004). 
Genotype-Environment Interaction in Schizophrenia Spectrum Disorder: 
Long-Term Follow-Up Study of Finnish Adoptees. Retrieved January 8, 2010, 
from http://bjp.rcpsych.org/cgi/content/full/bjprcpsych;184/3/216 
Trump, L., & Hugo, C. (2006). The Barriers Preventing Effective Treatment of South 
African Patients with Mental Health Problems. Retrieved December 18, 2010, 
from http://ajol.info/index.php/ajpsy/article/viewFile/30224/22841 
 76 
Venugopal, D., & Murali, N. (2010). Is there a “Behavioral Psychosis”? Retrieved 
September 14, 2010, from http://priory.com/psych/behpsyc.htm 
Whitley, B. (2002). Principles of Research in Behavioral Science (2nd ed). New York: 
The McGraw-Hill Company. 
Willig, C. (2001). Introducing Qualitative Research in Psychology. Buckingham: 
Open University Press. 
World Health Organization (2001). Mental Health: New Understanding, New Hope. 



















9.1.) Appendix A: Cover Letter to Psychiatrists 
 
The University of the Witwatersrand 
School of Human and Community Development 
Private Bag 3, Wits 2050, Johannesburg, South Africa 
Tel: 011 717 4500 Fax: 011 717 4559 
          
 Date: 
Honored Psychiatrist, 
My name is Nardus Saayman, and I am conducting a research study for the purposes 
of obtaining a Masters degree in Clinical Psychology at the University of the 
Witwatersrand. One of the requirements to fulfill the degree is to conduct a supervised 
research project. The research that I wish to conduct aims to look at the knowledge, 
attitudes, and practices of South African psychiatrists with regard to minimal 
medication interventions that incorporate psychological and/or psychosocial 
interventions in acute-phase schizophrenic psychosis. 
I would like to invite you to participate in the research. If you are interested in taking 
part, I will be conducting an interview either at your office, or in an office in the 
Emthonjeni Centre on the Wits campus, depending on your preference. The interview 
will last approximately 45 minutes and with your permission, I would like to record 
the interviews on a digital audio recorder. The recorded material will then be 
transcribed and interpreted. The digital audio recorder will be kept safe in a locked 
 78 
drawer, and only I, the researcher, and my supervisor will have access to the recorded 
and transcribed material.  
Because the interviews will be face to face, I cannot assure your anonymity. However, 
pseudonyms will be used in the research report and no personal identifying 
information will also be used in the research report. Therefore confidentiality will be 
maintained as far as is possible. 
The results will be reported in my research report, which is to be handed in to the 
Department of Psychology at Wits. Where necessary in the research report, in order to 
illustrate some of the points or arguments, I will need to use some direct quotations. 
This means that interviewee’s words may be reported directly, but given that any 
identifying information will be excluded or disguised, it will not be possible to link 
quotes to individuals. As per the Health Professions Counsel of South Africa’s 
guidelines the recorded material will be destroyed a minimum of 2 years after 
publication, and after a minimum of 6 years if not published. 
Your participation is entirely voluntary and you will not be advantaged or 
disadvantaged in any way should you choose to participate or not participate in the 
study. Should you choose to participate, you are also entitled not to answer any 
questions you find uncomfortable, and you can also terminate the interview at any 
time.  
If you choose to participate in the study, please will you sign the consent forms. You 
will be able to access the final research report in the William Cullen Library. It is also 
possible that the findings of the research report may be published in a journal.  
If you have any questions regarding this study, please don’t hesitate to contact me. 
Sincerely, 
Nardus Saayman (Student)    Patrick Connolly (Supervisor) 




9.2.) Appendix B: Interview Consent Form for Psychiatrists 
 
I, ______________________, a psychiatrist working in Johannesburg, South Africa, 
hereby agree to participate in the study and to be interviewed by Nardus Saayman. I 
understand that the research is for the purpose of his obtaining of a Masters degree in 
Psychology and that the study will look at the knowledge, attitudes, and practices of 
South African psychiatrists with regard to minimal medication interventions that 
incorporate psychological and/or psychosocial interventions in acute-phase 
schizophrenic psychosis. I understand that participation in this study is entirely 
voluntary and that no personal identifying information pertaining to me will be 
reported in the research, except for the use of direct quotes where required. 
Furthermore, I may choose not to answer any questions I find uncomfortable, and 
may terminate the interview at any point. I will be able to access the final research 
report in the William Cullen. It is possible that the findings of the research report may 












9.3.) Appendix C: Recording Consent Form for Psychiatrists 
 
I, ______________________, a psychiatrist working in South Africa, Johannesburg, 
hereby agree to participate in the study and for the interview to be recorded on a 
digital audio recorder by Nardus Saayman. I understand that all information given in 
the interview will be held privately by the researcher, Nardus Saayman. I also 
understand that direct quotes may be used in the final research report, but that all 
identifying information will be omitted if this should be the case. The digital audio 
recorder will be kept in a safe place and only the researcher, Nardus Saayman, and his 
supervisor will have access to the recorded and transcribed material. As per the Health 
Professions Counsel of South Africa’s guidelines the recorded material will be 







9.4.) Appendix D: Possible Interview Questions 
 
1. A.) According to you, what is the role of psychosocial interventions in acute-
phase schizophrenic psychosis? B.) Specifically, what do you think is the role 
of psychological interventions in acute-phase schizophrenic psychosis? 
2. According to you, what is the effectiveness of psychosocial interventions 
relative to the effectiveness of medication in the treatment of acute-phase 
schizophrenic psychosis? 
3. A number of projects in the world has experimented with minimal medication 
interventions that involve delaying medication, withholding medication, or 
giving very low dosages for an individual in acute-phase schizophrenic 
psychosis, all during an intensive psychosocial intervention: A.) Are you 
aware of any such projects or activities? B.) What is your opinion of such 
practices? 
4. What do you think is the practical viability of such approaches in the South 
African psychiatric health-care system at present? 
5. Have you ever delayed or withheld antipsychotic medication while assessing 
the effectiveness of an alternative intervention in acute-phase schizophrenic 
psychosis, and if so, under which circumstances did you do so? If not, why 
not? 
6. How does the response of a patient in acute-phase schizophrenic psychosis to 
psychosocial interventions in the hospital setting influence the dosage of 
medication that you prescribe?  
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9.5.) Appendix E: Standardized Explanation of Combined Minimal Medication 
and Psychosocial Interventions in Acute-Phase Schizophrenic Psychosis Based 
on the Soteria Model 
The proposed combined minimal medication interventions for the treatment of acute-
phase schizophrenic psychosis as proposed by Alan Mosher (2004), is largely based 
on the following three concepts:  
…the recognition of significant rates of recovery without drug 
treatment in early episode psychosis; the observation that many 
patients do not benefit from medications (through drug treatment 
resistance and noncompliance); and a valuing of interpersonal care 
and treatment of mentally ill patients (Bola & Mosher, 2003, p.220). 
This approach follows an unstructured guideline based on need-based intervention, 
and makes use of non-professional staff (Mosher, 2004. The use of antipsychotics are 
not automatically indicated in acute schizophrenic psychosis, with the focus being on 
interpersonal and therapeutic relationships. Social interventions are also incorporated, 
aimed at helping the patient reintegrate into the community by placing them with a 
surrogate family to support them. Five categories were identified that made the 
experimental setting significantly different from the control setting (representing 
standard hospital settings): approaches to social control that avoided codified rules, 
regulations, and policies; keeping basic administrative work to a minimum to allow a 
great deal of undifferentiated time; limiting intrusion into setting; working out social 
order on a face-to-face emergent basis; and commitment to a non-medical model that 
did not require symptom suppression.  
  
 
  
